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Introduction
In the latest years, the contributions of the Magnetic Resonance (MR)1
to the neuroscience were of fundamental importance, greatly increas-
ing our knowledge of the human brain. Recent neuroimaging methods
like Blood–Oxygenation Level–Dependent (BOLD) or perfusion–based
functional imaging and Magnetic Resonance Spectroscopy (MRS), offer
several chances for the knowledge of the function, and consequently the
dysfunction, of the human brain.
In particular, functional Magnetic Resonance Imaging (fMRI) has
been validated as a widely applicable and valuable tool for the scientific
and medical investigation of the Central Nervous System (CNS). How-
ever, fMRI suffers from various theoretical and practical limitations,
mainly related to its methodological approach, that relies on metabolic
and vascular phenomena. In fact, the observed signal does not reflect
directly the neuronal electrical activity, but it depends on the paramag-
netic properties of deoxyhemoglobin (dHb): the local variations of dHb
content modify the tissue T2, thus resulting in a variation of oppor-
tunely weighted MR images. dHb content in tissues is in turn related to
several parameters: vascular, such as blood flow and volume, and me-
tabolic, such as oxygen consumption. The functional variations of such
parameters, and their connections with neural activity, are still par-
tially unknown, although there is some evidence of a strong connection
1For a list of all acronyms utilized in this Thesis, see the Appendix B at page 101.
Acronyms are always defined at their first occurrence, and also afterwards when this
is suggested by clarity reasons. Atomic symbols, measure units and non–scientific
acronyms are not defined.
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between neuronal electrical activity and BOLD signal [1, 2].
From a practical point of view, BOLD maps are characterized by
poor temporal and not optimal spatial resolution: they are partially
limited by the intrinsic Signal–to–Noise Ratio (SNR) of the method, but
definitively by the vascular role in the signal generation, that introduces
a temporal and spatial spreading of information [3].
In this framework, a depth knowledge of the brain energetic and
vascular physiology is strictly required to optimize the use of current
techniques.
As far as the vascular issue is concerned, the spinal cord is a possible,
simplified model useful to study the characteristics of BOLD contrast;
its vascular anatomy shows a remarkable axial symmetry, which allows
a simpler modelling of fMRI signal. In the first Chapter, after a brief in-
troduction to the physics of the BOLD contrast, we will discuss in detail
the perspectives of spinal cord fMRI, and we will underline the medical
consequences of a non–invasive tool for assessing the functionality of the
injured spinal cord.
Drawing a comprehensive model of the physiologic–metabolic events
underlying neuronal activity is impaired by the difficult assessment of
the single dynamics of the parameters which generally influence the func-
tional signals. As already emphasized, the BOLD effect, at the basis of
the most widely used functional technique, results from the interplay
of cerebral blood flow, cerebral blood volume and cerebral oxygen con-
sumption. While the haemoglobin oxygenation has been evaluated with
high spatial and temporal resolution through the BOLD contrast and op-
tical methods, thus far the Cerebral Blood Volume (CBV) and Cerebral
Metabolic Rate of Oxygen (CMRO2) have not been suitably quantified.
A discussion on the role of these parameters for the investigation of
the physiologic features of brain activation, and the relevant modelling
studies, are given in the second Chapter.
A limited spatial and temporal resolution generally affects also the
in vivo measures of important metabolites, such as glucose or lactate.
This feature impairs the complete understanding of the basic events
of the activation metabolism. Proton Magnetic Resonance Spectroscopy
(1H–MRS), in particular, is often used in the study of brain metabolism,
in healthy subjects as well as in subjects suffering from several patholo-
gies. In the latter case, studies are aimed to identify possible markers
for the pathology characterization and diagnosis. The third Chapter is
devoted to our approach to quantitative 1H–MRS and to an application
to a specific pathology, the so called Migraine With Aura (MWA).
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As far as the metabolic issue is concerned, it was raised by the obser-
vation by Fox et al. [4, 5], obtained with Positron Emission Tomography
(PET), regarding a focal mismatch between CMRO2 , Cerebral Metabo-
lic Rate of Glucose (CMRGlc) and Cerebral Blood Flow (CBF) during
prolonged neuronal activity. This phenomenon was called ‘uncoupling’
and, in the opinion of the authors, it would be the manifestation of
anaerobic metabolism. To justify this assertion, they supposed that the
aerobic capacity of neurons is already saturated during basal condition.
Even though the hypothesis of non aerobic metabolism subserving neu-
ronal activity was consistent with Fox’s findings, it was not generally
accepted by the scientific community (see, for example, [6]), above all
because it appeared improbable that neurons were inefficient just when
they must work.
Despite the above described limitations in the general knowledge of
the basic events of the brain activation and in the techniques themselves,
several models of activation have been proposed during the latest decade.
Although none of them is able to give account of all the experimental
(and controversial) evidence presented in literature, they constitute a
valid basis for further developments.
A fundamental contribution in the interpretation of neuronal en-
ergetics was presented by Pellerin and Magistretti in 1994 [7]. These
authors proposed that astrocytes have a pivotal role in neuronal meta-
bolism, and that an Astrocyte–Neuron Lactate Shuttle (ANLS) could
support brain energetics by conveying lactate from astrocytes to neu-
rons. Consequently, lactate and not glucose was proposed as the prin-
cipal metabolic neuronal substrate during functional activity. In this
context, the importance of investigating the lactate variations in vivo is
evident. Changes in lactate concentration have been reported by means
of Nuclear Magnetic Resonance (NMR) spectroscopy upon prolonged
stimulations, and an increase of lactate concentration has been detected
by several authors during the first minutes of stimulation [8–10]. These
kind of studies [8, 9] were initially performed to investigate Fox’s hypoth-
esis, as an increase of lactate concentration was expected in consequence
of anaerobic glycolysis.
However, the above mentioned spectroscopic studies are not really
crucial to determine the basic events of activation; this is due to the low
temporal resolutions they achieved, and to the very prolonged stimula-
tions applied, during which the metabolic processes surely reach some
form of steady–state. Essentially, these studies were not able to detect
the metabolic dynamics, that necessarily follow a shorter time–scaling.
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A time–resolved 1H–MRS strategy was implemented by us in order to
measure the dynamics of lactate during the first seconds following a very
brief stimulus [11, 12]; during this temporal scale, a transient lactate de-
crease was observed. This decrease was interpreted by assuming that the
neuronal metabolism is aerobic from the early stage of their activation
and that the beginning of functional activity is accompanied by lactate
consumption. The fourth Chapter is entirely devoted to the discussion
of the metabolic events of the brain activation.
CHAPTER 1
Functional Imaging of the Central Nervous System
1.1 An introduction to BOLD contrast
The BOLD contrast relies on the paramagnetic properties of deoxyhe-
moglobin, that acts as endogenous contrast agent. The increase of meta-
bolism triggered by neuronal activity induces an enhancement of oxygen
consumption and a subsequent increase of local blood flow and volume.
The overcompensating increase of hemodynamic parameters produces
an overall decrease of tissutal deoxyhemoglobin content and thus an in-
crease of T2 and T
⋆
2; consequently, T2 and T
⋆
2–weighted images show
an intensity increase in activated regions. Such an increase enables the
localization of the underlying neuronal activity.
The locally increased blood flow in regions of the brain chat be-
come active appears to be a consequence of increased energy utiliza-
tion, mainly at the synapse [13]. Precisely which processes account for
the metabolic changes is unclear. A major contribution to increased
energy utilization may arise from metabolic changes in adjacent astro-
cytes with the uptake of the excitatory neurotransmitter, glutamate [14].
Astrocytes are abundant in the brain and are found in close proxim-
ity to the neurones. Elegant Carbon Magnetic Resonance Spectroscopy
(13C–MRS) experiments have suggested a 1 : 1 coupling stoichiometry
of oxidative glucose metabolism with glutamate neurotransmitter cy-
cling between neurons and astrocytes [15]. However, it does not appear
as though there is necessarily a simple relationship between increased
energy utilization and increased blood flow. This is obvious particularly
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with consideration of inhibitory synaptic activity. More work needs to
be done to clarify the interpretation and mechanisms of coupling the
hemodynamic response to neuronal activity.
These observations highlight a fundamental characteristics of the
BOLD fMRI response. First, it should be useful for identifying changes
activation–related in grey matter (where the synapses are found). Sec-
ond, the changes measured reflect synaptic activity or a combination
of synaptic and dendritic electrical changes, but not neuronal activity
directly. Third, as cortical signal changes are triggered mainly by excita-
tory synaptic activity, at least under some conditions there should be a
direct relationship between neuronal discharge rate and the magnitude
of the BOLD signal. The exact nature of this relationship was clearly
assessed by Logothetis et al. [1], that obtained simultaneous fMRI re-
sponses and intracortical recordings of neural signals in monkeys. They
observed that the BOLD responses can be estimated from Local Field
Potentials, thus suggesting that the BOLD contrast mechanism reflects
the input and intracortical processing of a given area rather than its
spiking output.
BOLD fMRI images signal contrast arises from changes in the local
magnetic susceptibility. Normal blood can be considered simply as a con-
centrated solution of haemoglobin (10÷ 15 g/100 cm3). When bound to
oxygen, haemoglobin is diamagnetic, while deoxygenated haemoglobin is
paramagnetic. Magnetic flux is reduced in diamagnetic materials, i.e. the
applied magnetic field is repelled. Paramagnetic materials. in contrast,
have an increased magnetic flux. A change in haemoglobin oxygenation
therefore leads to changes in the local distortions of a magnetic field
applied to it. Thulborn et al. [16] demonstrated that the T2 of blood
varies exponentially with the proportion of deoxygenated haemoglobin
in a fashion precise enough to allow determination of blood oxygenation
directly from the line width (which is proportional to T2) of the water
proton . The effect was shown to increase with applied magnetic held
strength, as predicted for a phenomenon based on differences in mag-
netic susceptibility. However, it was Ogawa who described the first true
Blood–Oxygenation Level–Dependent (BOLD) contrast imaging experi-
ment with a report that gradient–echo MR images of a cat brain showed
signal loss around blood vessels when the animal was made hypoxic [17].
This effect was reversed with normoxia. Ogawa then had the insight to
suggest that the effect could be used to image the smaller changes in
the blood oxygenation that accompany neuronal activation in the brain.
In fact, the experiments of Thulborn (characterizing T2 changes) and
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Ogawa (characterizing T⋆2 changes) define distinct phenomena, although
they are related.
Increased oxygenation of blood gives rise to increased signal from wa-
ter both in blood vessels and from the surrounding brain tissue, but the
mechanisms are somewhat different. Both T2 and T
⋆
2 changes contribute
to BOLD contrast.
As regards as the signal inside a vessel, this is effectively a single
compartment. Water diffuses freely between red blood cells and serum,
but cannot exchange across the vessel wall to a significant extent in the
time course of a single Echo Time (TE) (typically 50 ms or less). How-
ever, during this time, a water molecule can diffuse in or out of a red
blood cell. In consequence, its resonance frequency shifts because of the
rapidly changing magnetic fields immediately around and inside each
red blood cell. As the blood oxygen content decreases, the magnitude
of these local magnetic field differences increases with the proportion of
haemoglobin that changes from a diamagnetic to paramagnetic state.
This gives rise to water Magnetic Resonance Imaging (MRI) signal de-
crease from a T2 effect.
As regards as the signal immediately surrounding a vessel, with blood
deoxygenation, extravascular water within a voxel located close to the
vessel experiences a significant local field gradient across the voxel, the
magnitude of which depends on the proximity and relative orientation
of the vessel and the extent of the change in haemoglobin oxygenation.
In fact, modelling the vessel as an infinite cylinder with axis −→a , the
perturbation to B0 in a point P outside the vessel can be expressed, in
terms of angular frequency, as follows [18]:
(1.1) ∆ωB(P ) = 2pi∆χ0(1− Y )ω0
(rb
r
)2
sin2(θ)cos(2φ),
where ∆χ0 is the susceptibility difference corresponding to blood totally
deoxygenated, Y is the fraction of oxygenated blood, rb is the radius of
the vessel, r is the magnitude of the distance −→r of P from the vessel,
θ is the angle between
−→
B0 and
−→a , and φ is the angle between −→r and
the component of
−→
B0 in the plane perpendicular to
−→a that contains P .
As it is apparent from Eq. (1.1), (and as it was repeatedly observed, see
for instance [19]), the perturbation in P is maximal when the vessel is
perpendicular to the static magnetic field and vanishes when the vessel
is parallel to
−→
B0.
The variation in magnetic field across the voxel leads to signal de-
phasing and hence to a T⋆2 signal loss. Additional T2 loss occurs if the
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water diffuses significantly through the field gradient. The ratio between
T2 and T
⋆
2 components of the extravascular BOLD signal loss depends
essentially from the size of the vessel: the T⋆2 component prevails when
the radial diffusion path of the water molecules is small related to the
typical size of the vessel generating the gradient, or, in other words, in
proximity of large vessels, while the T2 component prevail in proximity
of small vessels.
The model developed in 1993, Ogawa et al. [18] was able to suc-
cessfully account for the main peculiarities of BOLD contrast, as the
dependence on the kind of sequence utilized, the dependence on the
orientation of the magnetic field, and the dependence on the degree of
blood oxygenation. The physical analysis of BOLD phenomena has later
been deepened also by other groups [20, 21], which described the BOLD
signal in terms of static and dynamic averaging, differentiating between
intravascular and extravascular effects. In any case, by simply consid-
ering the contribution of the extravascular spins [18], two important
formulas can be derived:
R⋆2 = α{∆χ0ω0(1− Y )}bV l (large vessels)(1.2)
R⋆2 = η{∆χ0ω0(1− Y )}
2bV sp (small vessels)(1.3)
where R⋆2 = 1/T
⋆
2, α and η are constants, ∆χ0 is the maximum suscepti-
bility difference which is expected in the presence of fully deoxygenated
blood, ω0 is the static magnetic field in angular units, Y is the frac-
tion of oxygenated blood, bV l and bV s are the blood volumes for large
vessels and small vessels, p is the fraction of active small vessels (i.e.
filled with dHb–containing red blood cells). Eq. (1.2) and (1.3) have
the key features of linking the measured signal with those physiological
parameters, which vary during activation. The deoxygenated blood frac-
tion 1 − Y is related to oxygen consumption and blood flow according
to 1 − Y = CMRO2/CBF. From Eq. (1.2) and (1.3) it is evident that
an increase of blood volume or oxygen consumption results in a signal
decrease, while a CBF increase corresponds to a signal rise.
During neuronal activation, a positive signal peak is detected in the
activated region (for example, see [22]). Whereas this observation is un-
questionably related to a decrease of dHb content, how such a decrease
in dHb occurs is not clear. In fact, while it is widely accepted that CBF
and CBV rise during activation, the entity of the elevation of CMRO2 is
not definitively established. Previous data, obtained by means of PET
[4, 5], indicated a small increase of CMRO2 (+0÷ 5%) compared to the
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large increase of CBF (+30 ÷ 50%) during elevated neuronal activity.
Qualitatively, the BOLD signal increase is certainly consistent with this
finding when considering the extravascular effects alone. Nonetheless,
the changes in neuronal physiology in response to a stimulation remains
a matter of intense debate, since the BOLD signal derives from the mul-
tiple interaction of CBF, CBV and CMRO2 , each of which may have a
characteristic temporal behavior.
When high temporal resolution and sensitivity is achieved, the BOLD
signal can show a complex time–course. In addition to the large, well–
studied signal rise usually detected in order to assess the activated areas,
an early (weak) dip of the signal within the first 3 s was observed by
some groups at high magnetic fields [23–27], and also (but with scarce re-
producibility) at 1.5 T [28]. For stimulation longer than 4 s, moreover, a
signal decrease below the baseline was seen towards the end of the time–
course. This later undershoot was observed even in the very first fMRI
papers, and probably originates from the different time–scales necessary
to CBV and CBF to recover the basal condition (volume effects).
The initial dip of the BOLD signal proves very interesting in what it
tells us about the dynamical coupling of oxygen metabolism and blood
flow. It can be interpreted in terms of an early increase in oxygen me-
tabolism accomplished by an increase in oxygen extraction before the
flow increase has started, as suggested by Malonek and Grinvald [6].
Nonetheless, in principle, the initial dip could simply derive from vol-
ume effects [29, 30]: an initial dip would indeed result if blood volume
reacts more rapidly than blood flow, without making any particular hy-
pothesis about the evolution of oxygen consumption.
Changes in T⋆2 relaxation times for extravascular water become grea-
ter with higher imaging magnetic field strength, but for large vessels the
increase is linear and for small vessels the increase is quadratic (see
Eq. (1.2-1.3)) . Thus, at higher magnetic fields the contribution of small
vessels should increase [3, 31]. However, at usual clinical 1.5 T field
strengths, there is a major intravascular component which can limit the
accuracy with which an activation volume in the brain parenchyma can
be mapped.
1.2 Towards a simplified model: fMRI of the spinal cord
The fMRI based on BOLD contrast [1, 17, 32–35] has gained a primary
role in the study of human brain, both for the characterization of normal
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brain activity and in clinical practice. After its introduction in the early
Nineties, the BOLD–based functional imaging was widely utilized for
non–invasive studies on human brain function; up to now, however, only
few studies of the human spinal cord by functional imaging have been
presented, starting from the work published in 1996 by Yoshizawa et al.
[36], with a subsequent strong contribution of Stroman et al. [37–45].
Even if the complex interplay of phenomena producing the BOLD
contrast in brain is still under investigation, it is expected that similar
phenomena should appear also in the spinal cord, and techniques based
on the standard BOLD contrast should be in principle applicable also
to the spinal cord, thus revealing areas of spinal activation in correspon-
dence of a given task involving peripheral nerves activity. In particular,
a motor task should activate motor neurons, in the anterior horns of
the spinal grey matter, while sensory and proprioceptive input produces
diffused response, with synapses in different locations [46], mainly in
the posterior horns (Fig. 1.1). A second source of functional contrast
has been hypothesized as active in the spinal cord fMRI: the so–called
Signal Enhancement by Extravascular water Protons (SEEP) [41]. The
same contrast was observed also in the brain [43, 47, 48].
Ventralnerve root
Spinal nerve
Anterior spinal artery
Grey matter
White matter
Dorsal horn
Anterior median fissure
Dorsal nerve root
Ventral horn
Anterior radicular artery
Posterior spinal artery
Radicular artery
Pial plexus
Central canal
Radicular vein
R L
Posterior radicular artery
Figure 1.1: Schematic of the human spinal cord. For clarity reasons,
arteries are drawn only on the right side of the cord, veins only on the left.
From [49].
The current knowledge on spinal cord function is based on invasive
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neurophysiology experiments, mainly on cats and primates [50]. At mo-
ment, no adequate and reliable methods are widely available for the
non–invasive clinical evaluation of spinal function. The regular applica-
tion of fMRI of human spinal cord would be of great importance in the
clinical practice, in particular for the assessment of functionality after
injuries, especially when patients are unable to report sensation or to
produce a movement, for the follow–up of the treatments, for the design
and assessment of rehabilitation programs. Moreover, the study of spinal
activity anomalies, also upon electric nerve stimulation, could improve
the comprehension and the treatment of chronical pain.
In the recent years, several progresses have been made in the treat-
ment of spinal injuries; the recent technical advances, like the regen-
eration of damaged neural tissue after injuries up to now considered
intractable [51–60], require a reliable method to assess the recovery of
functional activity.
A challenging perspective would be the integration of current knowl-
edge of spinal cord neuroanatomy with several different magnetic res-
onance measures, like fMRI, ordinary imaging, MRS, Diffusion Tensor
Imaging (DTI). In particular, MRS can provide useful data on spinal
cord metabolism, while DTI can give information on spatial and causal
relations between activated regions. MRS [61, 62] and DTI studies [63–
70] on human spinal cord have been conducted so far, demonstrating
the feasibility of such techniques in this problematic region.
Spinal cord activation has been observed in cervical and lumbar
spinal cord, for both sensory stimulation [37–42, 44–46, 71] and mo-
tor task [36, 38, 39, 45, 46, 71]. Spatial specificity for the stimulation
of different dermatomes has been shown [40] and also the differentia-
tion of motor and sensory areas was observed, although large overlaps
were found (see page 24 for a discussion on the spatial localization of
signal and Table 1.1 for a global survey of spinal cord fMRI experi-
ments published so far). However, obtaining BOLD images of the spinal
cord activation still remains a technical challenge. This is due mostly to
the small cross–sectional area of the spine, to cardiac–related motion of
Cerebro–Spinal Fluid (CSF) and of spinal cord itself [72–75], and finally
to the susceptibility artifacts, related to the proximity of tissues with dif-
ferent magnetic properties (e.g. the vertebral processes [62], and organs
like lungs, that have variable volume and several tissue–air interfaces).
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Table 1.1: Summary of fMRI experiments on human spinal cord.
Ref. Sequence Region Field/coil
[36] FLASH–2D (FC), TE/TR = 40/190 ms, FA = 40 ◦,
FOV = 200 mm, 256× 256
S C7–C8 1.5 T/neck coil
Fist clenching of the right hand @ 2 Hz.
[37] A: Modified FLASH (FC, †), TE/TR = 30/80 ms, FA =
30 ◦, FOV = 200 mm, 256× 128
S C8 3 T/surface coil
(∅ 17 cm)
B: Modified FLASH (FC, †), TE/TR = 30/80 ms, FA =
30 ◦, FOV = 200 mm, 256× 128
Sagittal
Squeezing a rubber bulb with the dominant hand @ 1 Hz. † : Spatial selective pulses outside the
imaging slab, breath holding during acquisition.
[38] A: GE EPI (FC, SSP, ‡), TE/TR = 31/5000 ms, FOV =
100 mm, 64× 64
B C6–T1 1.5 T/surface
coil
B: SE EPI (FC, SSP, ‡), TE/TR = 34/5000 ms, FOV =
100 mm, 64× 64
Squeezing a rubber bulb with the hand @ 1 Hz (A–B). Blowing puffs of air onto the center of one
hand (A). ‡ : Images acquired only after end–expiration.
[39] SSFSE (FC, SSP), TE/TR = 36, 66, 96/7000 ms, FOV =
120 mm, 128× 128
B C6–T1 1.5 T/phased–
array spine coil
Squeezing a bulb with one hand (left and right in separate experiments) @ 1 Hz. Thermal stimulation
with a bag of cool (5÷ 7◦C) water on the palm of one hand (left and right in separate experiments).
[71] GE EPI (RS), TE/TR = 50/3000 ms, FA = 90 ◦, FOV =
140, 160, 200 mm, 128× 128
B C4–T2 1.5 T/neck coil
Flexing the forearm about the elbow from 0 ◦to 90 ◦and back (1 ÷ 2 Hz). Wrist extension task with
clenched fist (1÷2 Hz) Fingers abduction–adduction task (1 ÷ 2 Hz) Holding random weights (from
0.3 to 1.2 kg) in one hand, with fixed flexed–arm position, 30 s for each weight.
[46] A: Multishot EPI (SSP, §), TE/TR = 50/68 ms, FA =
15 ◦, FOV = 250 mm, 128× 128,
Sagittal 1.5 T/neck coil
B: Multishot EPI (SSP, §), TE/TR = 50/100 ms, FA =
30 ◦, FOV = 250 mm, 256× 256,
B C6–C7
Alternated fist clenching @1 Hz. Alternated electrical median nerve stimulation at the elbow @ 1 Hz.
§ : Cardiac gating.
[40] SSFSE (SSP), TE/TR = 38/9000 ms, FOV = 120 mm,
128× 128
B C4/C5–
T1
1.5 T/phased–
array spine coil
Thermal stimulation provided by circulation of water (5÷ 7◦C, 30÷ 32◦C) in coils of rubber tubing
in contact with three different sensory dermatomes on the right hand and forearm.
[41] FSE (FC), TE/TR = 11, 22, 44, 55, 66/3000 ms, FOV =
120 mm, 128× 128
S C6–C8 1.5 T
Thermal stimulation provided with a cold pack (7◦C) placed on the palm of the right hand.
[42] SSFSE (FC, SSP), TE/TR = 34/8250 ms, FOV =
120 mm, 128× 128
S L1–L5 1.5 T/phased–
array spine coil
Thermal stimulation provided by different temperatures probe (2÷ 32◦C) placed on the inner calf.
[44] SSFSE (FC, SSP), TE/TR = 34/8250 ms, FOV =
120 mm, 128× 128
S T11–L2 1.5 T/phased–
array spine coil
Thermal stimulation provided by different temperatures probe (10÷ 32◦C) placed on the inner calf.
[45] SSFSE (SSP), TE/TR = 42.3/11000 ms, FOV = 120 mm,
128× 128
S S3–L1 1.5 T/phased–
array spine coil
Rhythmic flexion and extension movements (active and passive) of the ankles with a pedaling device.
The table contains the main parameters of all spinal cord fMRI experiments published on journals, in
chronological order. Ref.: reference of the study; Sequence: pulse sequence with relevant parameters and
(between parenthesis) additional settings; Region: localization of slices, reported as spinal cord segments (S)
or vertebral bodies (B); Field/coil: Magnitude of the magnetic field and receiver coil utilized; FC: Gradients
for the compensation of flux through slices; SSP: Spatial Saturation Pulses; RS: Ramp Sampling. Slices
are axial or perpendicular to the spinal cord if no otherwise stated. Also a brief description of the task
executed by the subject is given. From [49].
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1.2.1 Technical challenges
Vasculature
The spinal cord receives blood from 3 major arteries that run through
the length of the cord, one anterior spinal artery that lies in the ante-
rior median fissure, and two posterior spinal arteries that run near the
dorsal roots entry zones (Fig. 1.1, in red). The anterior spinal artery
branches and penetrates into the grey matter of the cord by way of the
anterior median fissure. It supplies the anterior two–thirds of the cord.
Posterior spinal arteries supply the dorsal white matter and the dorsal
horns, for about one–third of the cord. There is a limited anastomosis
between the anterior and posterior spinal arteries. The spinal arteries
receive blood from segmental radicular arteries which enter the verte-
bral canal through intervertebral foramina, continue along the nerve
root and branch into anterior and posterior radicular artery, which join
the spinal arteries. There are numerous anastomoses among spinal and
radicular arteries. Together, they form an irregular net of arteries and
arterioles on the surface of the pial matter called the pial plexus. Radic-
ular arteries arise from large vessels outside the vertebral column, such
as cervical arteries, intercostal and lumbar branches from the abdominal
and thoracic aorta [76]. Therefore larger arteries (diameter 0.1÷0.2 mm)
lie externally to the spinal cord, and have longitudinal symmetry, while
only small arterioles (maximum 50 µm) penetrate radially into the cord.
The veins draining the spinal cord (Fig. 1.1, in blue) are arranged
roughly like the arteries. There are usually 3 anterior and 3 posterior
(in general larger) spinal veins, one medial and two lateral, that run
longitudinally. They communicate freely and drain into radicular veins
that cross the subarachnoid space attached to the nerve roots, like the
radicular arteries. Radicular veins course into the epidural plexus and
join veins of the vertebral bodies. There, they run to the vertebral,
intercostal, lumbar and sacral veins. Also for veins, the main vessels
are external to the cord and longitudinally disposed, while the internal
drainage is provided by small, radial venules (diameter less than 50 µm)
[76].
This particular distribution of large vessels, only on the surface of
the spinal cord, should enhance the specificity of BOLD signal, even
with T⋆2–weighting, due to the inherent elimination of the confound-
ing, unspecific effect of larger vessels [77] from the grey matter signal.
Nonetheless the small cross–sectional diameter of the spinal cord makes
possible the large pial vessels to obscure the weaker signal from inside
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the cord, especially if motion artifacts are not under control.
However, the BOLD signal arising from large venous vessels should
be greatly reduced, due to their axial symmetry, parallel to the static
magnetic field
−→
B0. Similarly, the disposition of small vessels, all radial
and thus orthogonal to
−→
B0, should emphasize the dephasing effect of
deoxyhemoglobin. (see Eq. (1.1)); moreover, the intravascular contribu-
tion can be neglected for large vessels, as they lie externally to the spinal
cord.
Therefore the vascular anatomy of spinal cord is optimally organized
for the generation of strong and spatially specific BOLD effect. This
can help in overcoming the numerous other difficulties that involves the
spinal cord fMRI. However, it must be pointed out that some cases of
activation following the shape of small radial veins have been reported
[71].
Motion artifacts
The motion of CSF and spinal cord during cardiac and respiratory cycles
produces significant degradation of the functional MR signal. Although
the different motions are related to physiological rhythms and not to
the stimulation paradigm, partial volume effect can mimic the func-
tional contrast via partial volume averaging, especially at the boundary
of spinal cord with CSF and with the main vessels. The onset of partial
volume averaging contrast at the boundary of white and grey matter
appears less serious, given the low imaging contrast generally obtained
between grey and white matter [45]. In this case, the more prominent
effect would be rather a decrease of functional contrast, due to the av-
erage of active grey matter with white matter zone, that doesn’t show
signal increase.
Motion artifacts arise from several correlated factors: blood and CSF
flux, motion of spinal cord itself [72, 78] and body movements, enhanced
by the intrinsic mobility of the spinal cord [73]. Internal body movements
are mainly respiratory related, but unfortunately there is also a task–
related component (especially for motor tasks or with nerve stimulation)
that can be managed with more difficulties than in conventional brain
fMRI. This fact introduces the further problem of possible misregistra-
tion of images, likely to occur also due to the inhomogeneity of sur-
rounding tissue. Task–related movement artifacts were observed on the
cord surface, within large vessels and within neck and shoulder muscles
[37, 42, 46]. Very often the functional analysis was conducted only inside
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the spinal cord tissue, thus masking external artifactual activations.
In particular, the peak velocity of CSF, reported to be about 3 cm/s
(see below, page 16) can easily cause the inflow of unsaturated CSF.
Even if in the typical slice acquisition time the CSF can cover at most
one fourth of the slice thickness, the TR utilized generally allows a
complete CSF turnover in the slice slab.
A further complication for the application of spinal cord fMRI in
clinical routine is introduced by pathological movements of the spinal
cord, that are possibly larger, faster or simply different from the normal
ones, especially in compressive or degenerative diseases [74, 79, 80]. The
effects on quality of functional images are still unknown.
It has been suggested that the motion contribution to the signal can
be assessed at the spinal cord boundary, as the relative increase of signal
due to motion artifacts is greater than the true BOLD signal in a ratio of
at least 2 : 1 and has a greater variance [37, 45]. Sometimes, the excessive
magnitude of the contrast was assumed as a proof of motion and thus
utilized to exclude regions of artifactual activation [37, 38, 45], but this
approach is clearly unsatisfactory as it merely excludes the more gross
errors. Functional increases of signal as large as 12% [46] and 18% [45] at
1.5 T have been reported, and a substantial contribution of task–related
motion is supposed to contribute to such conspicuous variations.
The proposed approaches to reduce the quality degradation due to
motion rely mainly on subject constrain, breath holding and cardiac
triggering of the scans. Subject constrain was adopted [36, 37, 71] in
the form of head and neck restraining. Breath holding was sporadically
adopted [37, 38] to minimize the body movement and thus the related
artifacts; moreover, it reduces the susceptibility issues arising from lungs
volume variation. Nevertheless, breath holding can negatively affect the
functional imaging because it influences the hemodynamic and blood
oxygenation, and its effectiveness relies on the subject ability in main-
tain uniform lounge volume during the repeated breath holdings, so the
real advantages and consequences of this maneuver are not clear. Car-
diac triggering [46] permits to acquire slices with the most reproducible
saturation conditions of CSF, thus reducing the confounding effect of
unsaturated CSF inflow. However, the effects of task–related variations
of blood pressure cannot be avoided.
A further approach to motion artifacts relies on reducing the pixel
dimension, to improve the in–plane resolution. In fact, keeping small
the pixels reduces partial volume averaging and helps the recognition
of confounding structures, like vessels. Nevertheless the SNR decreases
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and can become too low, even when maintaining a comparably larger
slice thickness.
The software registration of images was always performed, sometimes
in the k–space [37, 39]. The rigid body rototranslation approach was
generally adopted. In order to minimize the effects of the shape or tone
changes of surrounding tissues, in particular muscles, the registration
procedure was often restricted to the spinal cord zone [36, 37, 39, 41, 42,
44, 45]. The resampling of the images has been also adopted to optimize
the spatial registration algorithm. [36, 37, 39]. Indeed, this stratagem,
that corresponds to a zero–filling in the k–space data, can minimize the
calculation errors for sub–pixel movements. A further proposed post–
processing step is the spatial averaging between adjacent slices [38], that
is expected to reduce the problems related to CSF flow, but at the
expense of loss of specificity and sensitivity.
Motion related artifacts can be minimized by acquiring the fMRI
time series time–locked with the relevant physiological parameters, res-
piration [37, 38] and cardiac pulsation [46]. In particular, the oscillating
CSF pulsation is a response to the transient increase of intracranial
blood volume during the cardiac cycle. The arterial inflow of blood has
an early systolic peak about 100 ms after the R wave of the ECG, while
the venous outflow is almost continuous with only a subtle diastolic
flow increase in the internal jugular vein. By considering the brain as
the main pump for the circulation of the CSF, an increased systolic
intracranial blood volume occurs mainly in the richly vascularized com-
partments of the brain. This causes the expansion of the grey matter
and then the compression of the intracranial subarachnoid space sur-
rounding the cerebral hemispheres. Therefore, a large volume of CSF is
initially displaced from the subarachnoid space into the cervical spinal
canal immediately after the inflow of systolic blood [72]. The downward
flow of CSF in the cervical spinal canal is delayed of about 100÷200 ms
compared to the arterial inflow [81].
In normal subjects, the caudally directed (systolic) CSF flow in the
anterior subarachnoid space reaches its maximum velocity immediately
after the beginning of the pulsation. In the literature, CSF velocity in
the cervical spine is reported to range from 0.8 cm/s to 4.0 cm/s. The
diastolic reflux is significantly slower [72, 82, 83]. The velocity decreases
as the CSF descends the spinal axis. The maximal velocity in healthy
volunteers occurs in the cervical area, at the C4–C5 level, and this is
probably due to the fact that at this level the spinal cord has the max-
imum section and the subarachnoid space is minimum. In the lumbar
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area, because the spinal cord extends only to the L2 level, leaving a large
subarachnoid space for CSF flux, the velocity is significantly lower.
The periodic changes in CSF flow with the cardiac cycle have a fre-
quency of about 1 Hz. In the cervical canal, this cardiac–related CSF
pulsation is superimposed upon an additional bulk component with a
period of several seconds, identified as related to inspiration and expira-
tion. The respiration–induced modulation of cardiac–related CSF flow
is subtle during normal respiration but clearly increases during forced
respiration. The respiration–related flux is directed mainly downwards
in the anterior subarachnoid space, upwards laterally. In addition, it
can be shown that the opposed components of CSF flow are not only
anatomically separated, but they alternate with time: caudal CSF flow
in the anterior cervical subarachnoid space dominates during inspira-
tion, whereas expiration is accompanied by an increase in cranial flow.
The increase of caudal CSF flow in the anterior cervical subarachnoid
space can be identified immediately after inspiration begins [72, 73].
The aforementioned knowledge suggests that the better approach to
motion artifacts reduction should be the acquisition of functional images
at about half of the interval between two consecutive hearth pulsations.
Pulsatile movement of both the brain and spinal cord is routinely
observed during neurosurgical intervention that involves the central ner-
vous system. Data obtained in healthy subjects indicate that the cer-
vical spinal cord moves in a craniocaudal oscillatory damped pattern
after cardiac systole. The alternating cranial and caudal spinal cord dis-
placement and velocity decrease to zero in the late cardiac cycle. This
pattern of oscillation differs from person to person. Measurements ob-
tained about 100 ms after cardiac systole showed that the spinal cord
moves first caudally, at a velocity of about 7 mm/s; this movement is
followed (about 160 ms after systole) by a cranial oscillation, with lower
velocity (about 3 mm/s), while CSF is still moving in caudal direction.
The measurement of caudal displacement of the spinal cord suggest a
maximum displacement of approximately 0.5÷1 mm. No definite motion
is seen in the middle thoracic spinal cord. Transverse velocities may ex-
ist within the spinal cord because of CSF pulsatility and systolic inflow
within the spinal cord tissue [75, 84–86].
Susceptibility artifacts
The quality of spinal cord functional maps is affected by local field
strong inhomogeneities arising from many different tissues adjacent to
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the spine, in particular bone [37]. Cooke et al. [62] recently mapped B0
inside the cervical spinal cord at 2 T, showing local distortions espe-
cially in proximity of spinous processes, with spatial periodicity roughly
equal to the length of the vertebral bodies. Nonetheless, B0 is relatively
uniform in the center of spinal cord and, as it is easy to guess, the ob-
served water linewidth decreased when spectroscopic voxel was shorter
in the Inferior–Superior (−→z ) direction, thus symmetrically spanning the
minimum number of interspinous spaces. These results strongly suggest
to set the imaging slices perpendicular to the bone and to adjust their
thickness and spacing so that each slice covers a vertebral body or an
intervertebral disc, avoiding the boundary zones between bone and con-
nective tissue.
Spinal cord fMRI was demonstrated in cervical and lumbar segments,
but not in correspondence of thoracic segment lower than T2. Below this
level, images quality and stability is compromised, probably by lung and
larynx motion, blood flow in the carotid artery, air in the trachea [36].
Sequence–related issues
At moment, a well established protocol for fMRI studies in spinal cord
doesn’t exist, nonetheless T2–weighted images were often obtained with
Single Shot Fast Spin Echo (SSFSE) sequence [39, 40, 42, 44, 45], that
suffers less than spin–echo Echo Planar Imaging (EPI) of quality prob-
lems, provides an overall better temporal resolution and is not contam-
inated by T⋆2-weighting, intrinsic in EPI imaging.
The sequence–related strategies most widely utilized to minimize the
effects of CSF flux and disturbing tissues are the presaturation of tissue
outside the imaging slab and the employing of gradients in the through–
slices direction for the flow compensation [36, 38–40, 42, 44–46], but
also the use of more sophisticate strategies is reported. Stroman et al.,
to maintain the same magnetization steady state inside and outside the
imaging sections, applied spatial selective pulses on sections 7.5 cm–
thick outside the imaging slab with a flip angle equal to the flip angle
of the slice selective pulses of functional imaging [37]. In order to min-
imize imaging artifacts due to long CSF T1, they utilized linear phase
encoding with Fast Low Angle SHot imaging (FLASH). This strategy
allows to obtain a steady state magnetization in CSF while most of the
k–space is sampled. The increased sensibility of this sequence to inflow
enhancement was managed with the aforesaid spatial selective pulses,
also in consideration of the absence of large vessels inside the spinal
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cord (see above, page 13). Nonetheless, this approach is reasonable only
for single slice imaging.
1.2.2 Signal characteristics
Signal magnitude and time–course
The maximum increase of fMRI signal, averaged on activated areas, has
been often evaluated (see Table 1.2 for a list of available measures), and
generally is stronger than in brain. See below, page 21, for a discussion
on this feature. The magnitude of BOLD response appears to be fairly
Table 1.2: Functional increase of fMRI signal in the human spinal cord.
Ref. Signal increase Task Sequence
contralateral ipsilateral
[36] 5% 2% Fist clenching FLASH
[37]† 7% Rubber bulb squeezing FLASH
[38] 3.8÷ 5.7% Rubber bulb squeezing GE EPI
4.8÷ 5.9% Rubber bulb squeezing SE EPI
3.2÷ 5.5% Blowing puffs on hand GE EPI
[39] 9% Rubber bulb squeezing, thermal stimula-
tion
SSFSE
[71] 0.5÷ 7.5% Various motor tasks GE EPI
[46] 8÷ 12% electrical stimulation, fist clenching Multishot
EPI
[40] 5% Thermal stimulation SSFSE
[41] 5÷ 6% Thermal stimulation FSE
[42] 2.6÷ 3.2% @29÷ 15◦C Thermal stimulation SSFSE
7.0% @10◦C
[44]‡ 2÷ 3% @29÷ 15◦C Thermal stimulation SSFSE
8% @10◦C
[45] 15% active task Motor task SSFSE
18% passive task
The table reports the maximum per cent increase of fMRI signal observed dur-
ing activation in ipsilateral and contralateral areas. Values in the middle are
averages off all active areas, ipsilateral and contralateral. Values are intersub-
ject averages, when applicable. Data acquired at 1.5 T, except † : 3 T. ‡: data
partially in common with [42]. See Table 1.1 for TE and further details on
experimental procedures and task. From [49].
independent of the side, dominant or not, of motor task or sensory stimu-
lation for hand exercises done in the same experimental conditions [38],
with a possible slight enhancement of magnitude of motor activation
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with non dominant hand [38].
The strength of signal depends on the intensity of stimulus. Stro-
man et al. observed an essentially biphasic dependence of per cent sig-
nal change on the temperature of thermal stimulus: the response slightly
increases when lowering the temperature from 29◦C to 15◦C, while be-
low this temperature the response is much larger [42, 45]. This fea-
ture has been related to the superimposition of the responses of two
classes of neurons identified in monkeys: high–threshold cold receptors,
that discharge at a rate linearly increasing with temperature decrease,
and should account for the slowly varying response, and mechanoth-
ermal nociceptors, whose discharge rate increases rapidly below 20◦C,
and should contribute to the sharp increment of response below 15◦C
[87, 88]. Madi et al. [71] observed a linear relationship between the force
applied by the muscles during an isometric task (variable weight hold-
ing) and fMRI signal. Both positive and negative correlation were found,
in different regions, while no voxel showing quadratic relationship was
identified. Invasive electrophysiological studies reported linear relation
between neural activity in the spine and contractile force [89]. In connec-
tion with this finding, the linear relation found by Madi et al. supports
the existence of a linear transfer function between neural activity and
fMRI signal in the spinal cord, as directly demonstrated in the brain
by Logothetis et al. [1]. However a direct proof of such linearity is still
lacking.
The temporal resolution of the studies is often limited by the tem-
poral averaging or filtering [37, 39–41, 46, 71]. Stroman and Ryner [38]
obtained the best temporal resolution, about 10 s, using EPI and the
breath–holding to reduce motion. The poor temporal resolution is a
strong limiting factor for the resolution of the shape of the transient
phases of the hemodynamic response.
The time to reach the maximum effect is substantially longer than in
brain, and has been evaluated in 20÷ 30 s for motor task and in about
15 s for sensory stimulation [38]. The slow rise of signal during the stimu-
lation has been regarded as an indirect proof that the observed variation
is related to physiology and is not artifactual, as most confounding ef-
fects (like motion or task–related flow) should increase immediately after
the onset of the task [38]. The ostensible slowness of fMRI signal dur-
ing blocked tasks strongly suggests an impulsive hemodynamic response
function (hrf) different and slower than in brain. The physiological rea-
son for this feature is not clear, even if the SEEP enhancement has been
involved (see below, page 21). It is nonetheless crucial the effective as-
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sessment of the spinal hrf, necessary also for the ordinary statistical data
processing.
Origins of functional contrast
In the BOLD model, the fractional signal change ∆S/S in T⋆2–weighted
images of grey matter tissues can be approximated as a decay linear on
TE [19]:
(1.4)
∆S
S
≈ −TE∆
(
1
T⋆2
)
Therefore, if no other phenomena are involved, the expected fractional
signal change can be extrapolated to 0 for TE = 0 s
Measures of ∆S/S vs TE in T2–weighted images of spinal cord under
motor or sensory stimulation gave a good linear fitting, but in the motor
task data a strange dependence of the slope of the linear fit on the order
of data collection (from longer to shorter TE or vice versa) has been
reported [39]. This unexpected characteristic, that doesn’t affect data
acquired during sensory stimulation, seems to be related to some sys-
tematic effect more than to a real physical feature. However, the fittings
consistently showed a nonzero intercept, in the order of +2%. Further
measures, conducted with shorter TE, seem to confirm the nonzero ex-
trapolation, but suggest also a non linear dependence of ∆S/S on TE,
at TE shorter than about 35 ms [41].
Stroman et al. observed similar functional contrasts with Gradient
Echo (GE) EPI and Spin Echo (SE) EPI, in the same experimental con-
ditions [38], while in the brain T⋆2–weighting provides a contrast con-
siderably stronger than T2–weighting [90]. Furthermore, the contrast is
often higher than in brain under similar experimental conditions (Ta-
ble 1.2). A partial explanation for this feature can be found in the dif-
ferences of vascular anatomy between brain and spinal cord. As already
discussed (see above, page 13), the vessels of spinal cord are optimally
arranged for producing a strong and spatially specific BOLD contrast,
with little intravascular contribution (that dominates the BOLD effect
in brain at 1.5 T) and little static averaging (that is observed in T⋆2–
weighted images but not in T2–weighted ones) [18]. Thus, the signal loss
is dominated by diffusion effects and therefore is mainly a T2–effect,
which produces similar contrasts in GE and SE images. A further fac-
tor is the anatomy of grey matter, that has a simple shape, without
tortuosity and thus allows the best functional homogeneity of imaging
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voxel, further enhanced by the good in–plane resolution often reached,
giving less partial–averaging effects. However, while these components
can account for similar (and increased) T2 and T
⋆
2 contrasts, they cannot
explain the nonzero extrapolation of ∆S/S vs TE at TE = 0 s.
This phenomenon can be explained with a non linear trend of ∆S/S
at short TE. Static dephasing and diffusion near vessels contribute non–
linearly to relaxation, but static dephasing is likely to have a minor role
(see above) and diffusion effects should contribute with a component
diverging from linearity only at longer TE and maintaining the zero
value at TE = 0 s. Less convincing is the observation of Stroman et
al. [39], that constant diffusion weighting vanishes in fractional signal
changes expressed as ratio between intensities obtained at the same TE,
as the issue is just if variable diffusion weighting, and thus different TEs,
can cause a non–linearity sufficient to explain the nonzero intercept of
linear extrapolation of T2– and T
⋆
2–weighted signals to TE = 0 s.
Stroman et al. hypothesize that the increase of SE contrast and the
nonzero intercept of ∆S/S vs TE are related to a functional increase of
the baseline signal, not related to BOLD effect. They observe that, as a
consequence of the increased blood flow during activation, the intravas-
cular pressure increases, in particular in arteries. Thus the water flow
across the vessels walls can increment and the extravascular water at
equilibrium can have a overall increase. As a complemental alternative,
an increase in intracellular water can be suggested by the functional de-
crease of apparent diffusion coefficient observed by Darquie´ et al. [91],
attributed to neuronal swelling during activation. In both these condi-
tions, an enhancement of MRI signal is observed, due to the greater
amount of resonant protons [38].
Stroman et al. refer to this phenomenon as Signal Enhancement by
Extravascular water Protons (SEEP). In particular, in spinal cord fMRI
it is supposed to account for at least half of the functional contrast
[39, 41, 47, 92]. In conformity with this hypothesis, a functional increase
of signal of 3.3% was observed in T2–weighted images at TE = 11 ms
[41]. Given the long TR (3 s), this enhancement seems to be essentially
related to a proton–density change. Probably, the TR utilized is not
so long to completely rule out the presence of T1–weighting or in–flow
related enhancement, but similar results were found at TR up to 7 s
[39].
The nonzero extrapolation of ∆S/S vs TE at TE = 0 s in spin echo
EPI was observed also in the brain [43, 47, 48, 92], where a nearly zero
extrapolation in gradient echo EPI was also observed. Nonetheless, the
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extrapolated intercept for SE EPI (about 1%) was minor than in spinal
cord. If the baseline increase due to proton–density change occurs in
the same compartment where BOLD originates, gradient echo imaging
should be as sensitive to it as spin echo imaging. Authors conclude that
proton–density change should occur in an extravascular compartment
with a T⋆2 shorter than in vessels, where originates the largest fraction
of BOLD brain signal at 1.5 T, but with a T2 at least equal to blood one,
as the enhancement effect persists in SE images as long as the echo times
sampled. However this explanation implies that the functional variation
in T2–weighted images at 1.5 T reflects mainly the dephasing effect in
extravascular compartment, in contrast with the current models [21].
Furthermore, at 1.5 T the brain tissue T2 is known to be shorter than
blood one (either venous and arterial) [93], and not at lest equal, as
required by the proton–density change hypothesis. Finally, the nonzero
extrapolation was observed in the human brain also at 4 T and at 7 T
[94]. In this case, the introduction of diffusion weighting by means of
Stejskal-Tanner gradients removed the effect, thus strongly suggesting
the intravascular origin of the phenomenon.
In a further formulation, based on the fitting of spinal cord fMRI
data with a simple model, allowing for both T2 and baseline functional
variations in two compartments that non exchanges on the time scale of
TE, Stroman et al. were able to demonstrate that the observed contrast
variation in function of TE, and in particular the nonzero intercept, is
related to an increase of the baseline intensity of about 5 ÷ 6% during
spinal cord functional activation [41, 43]. However data are overfitted,
and the compartment supposed to be vascular seems to weight for about
45% of the baseline signal at rest, and only 55% of baseline resting signal
is referred to the compartment supposed to be tissue.
Neural pathways
The spinal cord is left–right symmetrical. Unlike the brain, in the spinal
cord the white matter is external, while the grey matter is inside, with a
typical butterfly–shaped section (Fig. 1.1). Spinal cord lies in a vertebral
canal, surrounded by CSF. There is also a central canal containing CSF
that runs the cord.
The ‘descending tracts’ of the white matter are formed by the ax-
ons of motor neurons that extends from the brain and form synapses
with dendrites of the neurons which lies in center and anterior (ventral)
regions of the spinal cord. The axons of these neurons exit the spinal
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cord grouped in the ventral nerve roots. Similarly, the sensory informa-
tion proceeding from peripheral nerves is relied to the spine by axons
grouped in the dorsal nerve roots, which form synapses with neurons
within the dorsal areas of the spine; the axons of these latter exit the
grey matter and form the ‘ascending tracts’ of white matter.
In total, 31 pairs of spinal nerves emerge from the spinal cord. Each
spinal nerve is formed by a pair of nerve roots (one dorsal and one
ventral), that joins at intervertebral foramina; thus the spinal nerves
are mixed nerves, as each contains both sensory axons (afferent to the
dorsal grey horn) and motor axons (efferent from the ventral grey horn).
A pair of spinal nerve and the corresponding four nerve roots define a
segment of the spinal cord, that is thus associated with a specific region
of the body. Nonetheless impulses reaching the spinal cord from one side
eventually pass, at various levels, to tracts running in the opposite side
of the spine (crossing over).
Finally, the spinal cord also acts as a minor coordinating center for
simple reflexes.
Distribution of neuronal activity with motor and sensory stimulations:
signal specificity
The main activation in spinal cord is expected to be ipsilateral with the
stimulation (see above, page 23). Nonetheless, also contralateral activa-
tion was often observed [36–38, 40, 42, 45, 46], occasionally intense as
the ipsilateral one [36, 46]. This is somewhat unexpected, and probably
interneurons activity cannot completely account for this phenomenon.
At moment, it is not clear whether the contralateral activations are ex-
pression of real contralateral activity, or they are simply artifacts. In
order to explain these activations, the regulation of motor control, or
even the execution of unobserved shadow movements or their conscious
inhibition have been involved [36]. Contralateral activation is expected
when muscle pain is involved, but a more prominent ipsilateral activa-
tion was instead observed with thermal noxious stimulation (2◦C) [42].
Very often motor stimulation resulted in an activation of the medi-
olateral zone of the grey matter, with a slight enhancement of ventral
horns. Sometimes also dorsal horns resulted active [36, 37], with inten-
sity comparable or even major than in ventral areas. The presence of
unexpected dorsal activation during motor tasks can be partially as-
cribed to proprioceptive input and – less probably – touch, in particular
for larger hand movements. In any case it is likely to reflect also the
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insufficient in–plane resolution and the uncorrect registration of images.
Ventral activation in correspondence to thermal stimulus [40, 42, 45]
is less surprising, due to interneurons activity. Dermatomes are inner-
vated by fibers from a single nerve, that connects to a single spinal
segment, but dermatomes partially overlap; the stimulation of single
dermatomes has been shown to roughly map to the corresponding spinal
areas [38, 40, 42, 45]. A certain degree of distribution of activation be-
tween adjacent spinal cord segments is nonetheless expected, in particu-
lar for thermal stimulation, as interneurons can spread the input to sev-
eral spinal segments [40, 42, 45]. Unfortunately, some differences in the
fMRI patterns corresponding to the stimulation of different dermatomes
is observed only after the application of a clustering postprocessing rou-
tine that facilitates the emergence of such a feature. If no clustering
is applied, the stimulation of different hand dermatomes induces fMRI
activation patterns that are indistinguishable from each other, and also
partially referable to false activations [40].
The activation spreading between segments was observed also dur-
ing motor tasks [45, 46, 71]. When specific motor tasks are used, de-
signed to require the movement of individual muscle groups innervated
by nerves proceeding from different spinal segments, the observed acti-
vation spreads on more segments than expected, but the activation in
extra segments is less consistent across subjects [71]. This finding sug-
gests a prominent intersubject variability, perhaps in relation of different
ability in the accurate execution of the task or also in the muscle inner-
vation. A possible artifactual origin of some unexpected features of the
signal can be hypothesized as well. Interestingly, also areas of reduced
BOLD response were observed; negative response was more diffuse than
positive one and it was similarly clustered [71].
The spreading of activation beyond the expected areas suggest to
conduct electromyography studies in conjunction with spine fMRI to
exactly assess the activated muscles.
fMRI in the injured spinal cord
Spinal cord fMRI has been recently conducted on subjects suffering from
traumatic injuries [42, 45]. Subjects demonstrated persistent activity in
the spinal cord below the lesion during a thermal stimulation. The pro-
vided thermal stimulation at the inner calf provoked response in the
lumbar region of the spinal cord. In healthy control subjects the main
activated areas was observed ipsilaterally, in particular in the dorsal
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horn, in the intermediate region and in the ventral region (motor area),
probably in relation with a withdraw reflex from thermal stimulation
[42]. Also a less prominent contralateral activity was observed, mainly
in the dorsal and intermediate region. In injured subjects the response
was diversified, according to the lesion: subjects with incomplete lesions
and capable of feeling, at least partially, the thermal stimulus, had ac-
tivity patterns similar to that observed in normal subjects. Subject with
incomplete lesions, but not able to feel the stimulus, had diminished ac-
tivity compared with control subjects, in particular in ipsilateral dorsal
areas. Subjects with complete spinal cord injuries, while showed consis-
tently less (but not null) ipsilateral dorsal activity, had ventral activity
increased both in the ipsilateral and contralateral ventral grey matter
[42, 45].
Such increase can be addressed if we accept that the activity in ven-
tral grey matter is normally related to reflex motor activity (withdrawal
from cold/noxious sensation) via interneurons; in this case the increased
activity would correspond to lack of inhibitory input descending from
the brain, due to the complete descending tracts disruption [45]. Follow-
ing this interpretation, subjects with incomplete lesions, but who cannot
feel the stimulus, have less ventral activity due to a descending inhibitory
input partially persistent. Nonetheless an objection to this view is that
in these subjects the inhibitory input descending from brain should be
reduced or absent, due to the interrupted ascending tracts that deprive
the brain of the sensory input to which the inhibition is the response.
The activation patterns in subjects with incomplete lesions, but who
cannot feel the stimulus, should be therefore more similar to those of
subjects with complete lesions. In any case, the reduced dorsal activity
in subjects that don’t feel the stimulus (due to either partial or complete
lesions) reflects presumably the disruption of ascending tracts and the
consequent lack of functionality (and thus fMRI–observable activity) of
neuronal bodies, whose axons has been interrupted, while interneurons
that project to adjacent spinal segments or to ventral areas continue to
function, and therefore account for the remaining observed activity [45].
Anyway, the simultaneous recording of somatosensory evoked potentials
and fMRI response in injured subjects is highly desirable to assess the
relationship between the fMRI spinal response and the really perceived
stimulation.
The per cent increase of functional signal in activated areas as a
function of the temperature of the stimulus was similar in controls and
in injured subjects: an increase of 2 ÷ 3% above the baseline was ob-
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served during stimulations between 29◦C and 15◦C, while below this
temperature the increase was larger, 7÷ 8% at 10◦C [42, 45]. This sug-
gests that traumatic injuries lower the number of functional neurons, but
that the functional neurons responde to stimulation as in non–injured
spinal cord.
Even if the amount of fMRI studies of the spinal cord is rapidly in-
creasing, the overall reliability of the functional maps is still debatable.
Sometime, functional studies fail, and the functional activation is missed,
even in case of no apparent degrading effect of motion [37]; furthermore,
the repeatability of results in single subject [44] and in intersubject [46]
studies is still not optimal. These factors notably impair the usefulness
of spinal cord fMRI in clinical routine, at least until a reasonable as-
sessment of variability sources will be available, either in physiological
and pathological subjects. At moment the weight of random factors,
like motion and random noise, compared to actual functional variations
between trials, can not be evaluated.
Despite the increasing amount of data, the persistent presence of
‘unexpected’ activation areas, in particular in contralateral zones, makes
still debatable the degree of spatial specificity and the origin of the sig-
nal. A direct proof that fMRI activation in spinal cord reflects neuronal
activity is still lacking. The intrinsic specificity of the SEEP contrast is
still unknown, both in brain and in spinal cord, even if it was shown
that BOLD and SEEP fMRI maps don’t overlap and a better specificity
of SEEP–based fMRI was suggested [43, 47].
Spinal cord fMRI in healthy and injured subjects has furnished find-
ings that generally are not surprising, as they were repeatedly observed
in animal models. Nevertheless spinal cord fMRI allows us to directly
observe those findings on humans, and promises to become a valuable
clinical and scientific tool for the non–invasive assessment of spinal cord
function.
1.2.3 Methods
In a preliminary study we examined at 1.5 T three healthy subjects
on the whole–body scanner (NV/i, General Electric Medical Systems,
Milwaukee, WI, USA) of Neuromed institute during a simple, blocked
motor task (finger–tapping of the right hand). Five functional slices were
acquired, centered on vertebrae and discs from the sixth cervical vertebra
to the first thoracic vertebra. In a first stage we investigated the influence
of the experimental parameters, such as the kind of coil (volume or
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surface), the kind of Echo–Planar sequence (SE or GE, single–shot or
multi–shot), the dimension of the Field Of View (FOV), the number of
the phase–encoding steps, the presence of spatial saturation pulses.
In order to identify the best TE, we roughly estimated the T⋆2 of
the spinal cord tissue, by acquiring with long Repetition Time (TR)
fully–relaxed T⋆2–weighted maps and fitting the amplitude of signal in
function of TE with a monoexponential decay (GE EPI, TR = 6000 ms,
TE = 32− 80 ms in 5 steps, Flip Angle (FA)= 90 ◦).
In the functional study two right–handed healthy subjects were ex-
amined , using a 3 inches surface coil. Subjects were requested to breath
evenly and to keep the neck as still and straight as possible. The subjects’
heads were restrained during the experiments by means of a custom head
immobilizer.
Gradient–echo (GE, TR/TE = 3000/40 ms, FA = 90 ◦) planar im-
ages were collected during the functional paradigm. The FOV was 10
cm, while images in–plane resolution was 128x64. Seven or five oblique
slices were acquired, perpendicular to spinal cord. Slices spanned respec-
tively from the fifth cervical vertebra (C5) to the first thoracic vertebra
(T1) (thickness = 9.5 mm, spacing = 0.0 mm) and from C6 to T1
(thickness = 9.0 mm, spacing = 0.0 mm). Thickness and spacing were
adjusted so that each slice was centered on a vertebra or on a interverte-
bral disc. Up to 6 presaturation regions were employed to suppress the
signal from outside the FOV and to reduce motion artifacts.
For the seven slices sequence the stimulation design involved 2 con-
ditions alternating every 30 s: rest and fist clenching of the right hand.
3 blocks were acquired, thus implying a total duration of 3 minutes.
For the five slices sequence the stimulation design involved 2 conditions
alternating every 40 s: fist clenching of the dominant (right) hand and
rest. Four functional blocks were acquired. Dummy images were acquired
before each fMRI series.
During the postprocessing, images were cropped to select only a
subregion containing the entire spinal canal, realigned using rigid body
rototranslations and smoothed with a gaussian kernel, Full–Width Half–
Maximum (FWHM)= 2.0 mm. Functional analysis [95] was then carried
out in the temporal domain on a pixel–by–pixel basis by computing
the deconvolution between the time course of each pixel and the task
paradigm, to assess the hrf. The signal waveform is supposed to be the
convolution of the hrf with the task paradigm; two terms accounting for
constant baseline and linear trend were added. Finally, the statistical F
map was obtained by solving a least–square problem.
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To obtain the time course of the BOLD signal we first averaged voxel
by voxel the four task blocks of the five–slices sequence, so obtaining
images corresponding to a single temporal series of 80 s, corresponding
to an off–on period. Then, voxels which p–value in F maps was less than
0.02, Bonferroni corrected, were averaged. Finally, adjacent time points
were averaged two by two, so obtaining an effective temporal resolution
of 6 s.
1.2.4 Results
During the preliminary study we found that the quality of the images
notably depends on the protocol of acquisition adopted and even on the
subject investigated. The application of presaturation pulses contributed
to reduce motion and susceptibility artifacts, but these were not com-
pletely avoided. In particular, the effect of the CSFflux was very often
observed at the boundaries of the spinal cord.
In a second stage the main objective concerned the optimization
of post processing, in order to correct the distortions that sometimes
impair the quality of functional images, and to adapt the current post–
processing algorithms to the peculiarities of the district. We focalized on
GE maps, that showed better activations, despite their notably worse
quality. By using volume coils the functional analysis of the images was
rarely possible. When obtained, the functional maps showed activation
spots at the level of the seventh cervical vertebra and adjacent disks,
clearly dominated by movement artifacts: the activation was bilateral,
with a preferential, unexpected, dorsal localization, almost entirely lying
at the boundaries of the cord and in the CSF (Fig. 1.2 A). Also zones
of negative signal were identified in adjacent slices (Fig. 1.2 B).
In Fig. 1.3 the same data of Fig. 1.2 A are shown. Unlike in Fig. 1.2,
here no correction for geometric distortion is applied, and the functional
map is superimposed to the mean EPI. A strong geometric distortion is
apparent.
We were able to obtain more reliable activation with the use of the
surface coil. To assess the non–artifactual origin of the signal, we esti-
mated the percentage variation of BOLD signal between rest and task
condition in activated voxels. The relaxation time experiment gave a
value of T⋆2 = 32± 2 ms, consequently, we set TE = 40 ms to optimize
the Contrast–to–Noise Ratio (CNR). We obtained reliable activation
maps in spinal cord, showing strong activation between C7 and T1, as
expected. The activation is ipsilateral, even if we observed a slightly
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Figure 1.2: A) Artifactual activation detected in GE images (p< 0.01) at
level of disc between C7 and T1. B) Regions of negative signal, detected
at level of C7 (p < 0.01). The maps are superimposed to a T1 reference.
From [96].
Figure 1.3: The quality of GE images obtained with volume coil is seri-
ously impaired by geometric distortion: the same GE image of Fig. 1.2 A,
not corrected for aberration and superimposed to mean EPI. From [96].
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enhanced anterior area activation thus suggesting a significant contribu-
tion of motor stimulation and a less contribution of sensory stimulation,
as expected (Fig. 1.4). The quality of EPI image should be compared to
that shown in Fig. 1.3.
Figure 1.4: A reliable activation was detected in GE images at level of
disc between C7 and T1. The map is superimposed to a cropped EPI. The
maximum value of colorbar (red) corresponds to F= 8, the minimum one
(dark blue) to F= 0. The activation map threshold is F= 6.900 (p= 0.004).
From [97].
In Fig. 1.5 is reported the average time course of BOLD signal dur-
ing a blocked motor stimulation. The average BOLD signal increase over
basal level during task condition was about 5.6%. The temporal resolu-
tion obtained (6 s) is ameliorative of the best results published so far by
Stromal et al. [38], who obtained a temporal resolution of about 10 s.
The temporal pattern shows a good agreement with the expected fea-
tures of a true–BOLD signal, with an initial overshoot (about 6 s after
the stimulation start) followed by a lower steady–state level.
Further investigations are required to identify the experimental con-
ditions more suitable to avoid susceptibility and motion artifacts, and
in particular to compensate the CSF flux.
In order to test the linearity of the BOLD signal in spinal cord in
response to stimulation of variable length, and to verify the possibility to
obtain the BOLD time course during these stimulations as convolution of
such impulsive response, we are measuring the impulsive hemodynamic
response in an event–related experiment.
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Figure 1.5: The average time course of BOLD signal during a blocked
motor stimulation (the gray bar corresponds to the motor task). During
the task, the average BOLD signal increase over basal level condition is
about 5.6%. Each data point represents a 6 seconds interval. Error bars
represent 2 SD of the scaled data. From [97].
CHAPTER 2
Physiology of the Brain Activity
Over the past decade, extraordinarily sensitive new techniques have been
developed to allow researchers to see what is happening inside the living,
functioning brain. Our knowledge of neuronal physiology and metabo-
lism during activation, nevertheless, still remains at a pioneering stage.
In particular, with the advent of the 1990’s, MRI techniques became
recognized as a revolutionary innovation in the outlining of functional
activity.
The most diffused strategy of fMRI relies on the so–called Blood–
Oxygenation Level–Dependent (BOLD) contrast [17, 32, 33], in which
signal changes in T2–weighted images are related to local variations in
the dHb content of the blood. The BOLD signal is not directly related
to electrical neuronal activity, but rather depends on the complex in-
teraction of several metabolic–vascular parameters – such as cerebral
CBF, CBV, and CMRO2 – that can not be individually separated and
characterized. As a consequence, the absence of a profound knowledge of
the metabolic–vascular events of neuronal activation can actually render
the interpretation of the signal ambiguous. The possible intervention of
modulating factors could also render the same metabolic–vascular dy-
namics extremely both condition and subject specific [98].
Fortunately, it is also possible to obtain mono–parametric, and thus
analytically quantifiable, information about the microvascular flow by
means of advanced NMR techniques, which enable a selective study of
perfusion without exogenous contrast agents [99]. Perfusion–based meth-
ods have been applied to functional imaging (for example, see [100]), and
have facilitated the proposal of new models for activation physiology by
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virtue of the comparison between BOLD–related and perfusion–related
signal changes.
Crucial information also has become feasible with several optical
methods, which enable to detect the changes in optical properties of
brain tissue associated with functional activity. Most importantly, these
techniques permit the tracing of the in vivo dHb dynamics, which can
thus be directly related with the time–course of the BOLD signal.
Further useful elements toward the understanding of neuronal acti-
vation derive from the in vivo Magnetic Resonance Spectroscopy, which
enables the detection of several metabolites that are strictly linked with
neuronal activity. Understanding the functional metabolic events is an
object of intense debate. The several efforts to link the cellular meta-
bolic phenomena with the macroscopic physiological changes remain to
provide definitive conclusions, even on the establishment of the main
metabolic substrate for neurons, if glucose or lactate.
2.1 Understanding the vascular network: the Balloon mo-
del
In order to quantitatively represent the BOLD signal S(t) as a function
of the physiological parameters that create the signal, three independent
measures would be necessary, given that:
(2.1) S(t) = f(CBF(t); CBV(t); CMRO2(t))
Obtaining three independent measures with high temporal resolution
is by no means an easy task. During a single session, only two fMRI
acquisitions are generally performed (typically BOLD and perfusion).
Reasonable physiological models must thus be formulated in order to
solve the problem of deducing the lacking parameter and fitting the
experimental BOLD signal.
In recent years, the so–called Balloon model, presented by Buxton
et al. in 1998 [101], has proved very popular, given that it attempts at
providing a simple and exhaustive description of how changes evoked in
the blood flow are transformed in the BOLD signal. This model can be
considered an evolution of the oxygen limitation model, presented by
Buxton and Frank in 1997 [102]. The oxygen limitation model furnished
a possible explanation for the large mismatch between the variations
of CBF and CMRO2 which was originally suggested by PET studies
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[4, 5] and later supported by the detection of the positive BOLD signal.
Buxton and Frank [101] showed that a large increase of flow is required
to support a small increase in oxygen metabolism where it is assumed
that:
• all oxygen which leaves capillaries is metabolized
• CBF increases occur through increases of blood velocity alone (ab-
sence of capillary recruitment).
The increased blood flow consequently reduces the Oxygen–Extracted
Fraction (OEF) due to the decreased capillary transit time. Given the
previous assumptions, and given that:
(2.2) CMRO2 = OEF · CBF · [O2]a
where [O2]a is the arterial O2 concentration, the rate of oxygen consump-
tion increases significantly less than blood flow. The oxygen limitation
model provides an interpretation of the observed positive BOLD sig-
nal in terms of a tight coupling, rather than uncoupling, between blood
flow and oxygen metabolism. Nonetheless, it does not explain the fine
BOLD time–course (especially the initial dip) [23–28], and it reveals
nothing about whether or not blood blow and oxygen metabolism are
coupled during fast dynamic changes. The Balloon model extends the
oxygen limitation model in order to solve the above question.
The essential element of the Balloon model regards the effects of flow
(the input of the system) on the blood volume and on the content of
dHb, which then reflect on the BOLD signal. Blood volume changes are
supposed to occur primarily in the venous compartment, which is also
assumed to contain all the dHb. The venous compartment, which is fed
by the output of the capillary bed, is considered to expand in the same
manner as a balloon in consequence of an increase of the volume flow
rate. Another key assumption regards the relationship between blood
volume and blood flow, which was mainly suggested by Grubb’s law
[103]:
(2.3) CBV = CBFα
where α = 0.4. In particular, Buxton et al. [101] considered the time–
course of volume change during the transition periods as different from
the behavior at steady state, as was also confirmed by the studies of
Mandeville et al. [104, 105]. The authors showed the Balloon model [101]
to successfully reproduce the experimental BOLD data, particularly the
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early dip and the subsequent undershoot of the signal. A strong argu-
ment in favor of the Balloon model has also been furnished by Friston et
al. [106]. These authors demonstrated that the Balloon model, suitably
extended to incorporate the dynamics of CBF induction by synaptic ac-
tivity, is sufficient in reproducing the main non–linearities observed in
evoked fMRI responses, such the one resulting from the hemodynamic
refractoriness. Nonetheless, different points of view have recently been
proposed, as that of Mintun et al. [107]. They constructed a mathemati-
cal framework showing that the tissue level of oxygen can be maintained
without the need for large increases in CBF, thus suggesting that CBF
is regulated by factors other than local requirements in oxygen.
In fact, some assumptions at the basis of the Balloon model still re-
quire independent experimental evidence, as the absence of recruitment,
which, in turn, implies the limited delivery of oxygen. The description of
microvasculature behavior represents one of the most debatable issues in
physiology, and it is impossible to exclude the occurrence of recruitment
when CBV increases. On the other hand, several recent estimations of
CBF and CMRO2 (see Table 2.1) quantitatively disagree with Fox et al’s
results [4, 5], even if these estimations qualitatively support the concept
that CMRO2 changes are smaller than the enhancement in CMRGlc and
CBF. Given these evidence, the strong hypothesis of a limitation in the
delivery of oxygen seem to be not completely justifiable.
2.2 The measurement of CMRO2
Of all the parameters which characterize the BOLD signal, CMRO2 is
certainly the most problematic, since it is not directly measurable. This
parameter, nevertheless, is fundamental in establishing what kind of
metabolism occurs during activation. The quantitative value of CMRO2 ,
which has been obtained in humans only in stationary conditions and
with a poor spatial resolution, greatly depends on how the estimation
is performed. This explains the large variability of those findings which
assess the changes of such parameter during neuronal activation (see
Table 2.1).
With regard to the PET strategy, the difficulties associated with
these measurements have often led to fervid skepticism about the va-
lidity of the data [4, 5, 108, 109, 111–113, 118, 120], which must be ac-
curately deconvolved from multiple measurements [129] with relatively
poor SNR. On the other hand, many ambiguities characterize the quan-
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Table 2.1: Variations of cerebral metabolic–hemodynamic parameters
measured during stimulation in healthy humans.
Ref. Method ∆CMRGlc ∆CBF ∆CMRO2
[4] PET +29% +5%
[108] PET +7%* +13%*
[5] PET +51% +50% +5%
[109] PET +40% +28%
[110] 1H–MRS +22%
[111] PET +15÷25% +15÷25%
[112] PET +27% +43% +0%
[113] PET +23.4%†
+11.7%‡
[114] Kety–Schmidt +12% +15% +0%
[10, 115] BOLD Perfusion 1H–MRS +21%
[116, 117] PET +50÷68% +22÷25%
[118] BOLD Perfusion +43% +6%
[119] BOLD Hypercapnia +45% +16%
[120] PET §
[121] BOLD Perfusion Hypercapnia +74% +4%
[122] BOLD Perfusion Hypercapnia +44% +16%
[123] BOLD Perfusion Hypercapnia +61% +2%
[124] BOLD Perfusion Hypercapnia +48%¶ +25%¶
[125] 13C–MRS < 30%
[126] 13C–MRS <∼ 60%
[127] BOLD Perfusion Hypercapnia ♦
*: averaged value referred to the entire brain; †: total value; ‡: oxidative value;
§: significant increase; ¶: value obtained with the most intense stimulus (with
less intense stimuli, what results is that ∆CBF : ∆CMRO2 = 2 : 1); ♦ ∆CBF :
∆CMRO2 = 3 : 1. From [128].
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titative estimation of CMRO2 also with MRI methods. In fact, the as-
sumptions upon which the procedure is based may well be debatable, as
the use of hypercapnia for calibrating the relationship between BOLD
and CBF/CMRO2 [119, 121–124, 127]. Hypercapnia could only be used
as a control reference upon hypothesizing that:
• there are no metabolic changes involved in the transition to and
from hypercapnia;
• hemodynamic responses during neuronal activation and during hy-
percapnia are similar.
Nevertheless, such hypotheses have not been proven in humans.
NMR spectroscopy can be used to measure the turn-over rate of
TriCarboxylic Acid (TCA) cycle following an injection of 13C–labelled
glucose, and therefore represent a valid tool in deducing CMRO2 [130].
Nonetheless, by means of such a strategy, Hyder et al. [131] reported
a 250 ÷ 300% increase in CMRO2 in anesthetized rats during single
forepaw stimulation, in dramatic contrast with the other data which
indicated small CMRO2 increases [4, 5]. These results led to a great deal
of criticism about the metabolic pathways utilized for the calculations
and about the use of anesthetized conditions. In any case, the recent
results obtained in human studies appear more convincing. In particular
the results of Chen et al. [125] impose a plausible upper limit of 30% for
the fractional changes in CMRO2 induced by a visual stimulation, while
the work by Chhina et al. [126] indicates an upper limit of 60%.
A promising alternative approach for CMRO2 measurements in func-
tional studies comes from the use of 17O NMR spectroscopy/imaging. As
recently demonstrated, at high fields the H2
17O produced by oxidative
metabolism can be directly detected in rats during 17O2 inhalation [132]
and in humans in natural abundance [31]. By means of such approach,
Zhu et al. determined [132] the quantitative resting value of CMRO2 in
the rat brain, with an optimal spatial and temporal resolution. Further
studies are nonetheless needed in order to overcome the great invasive-
ness of this strategy, which needs an implanted 17O RF coil to monitor
the arterial input function related to recirculated H2
17O.
2.3 The role of CBV
A very central assumption of the Balloon model, and generally of those
studies which attempt at providing a quantitative estimation of CMRO2
with MRI, is the validity of Grubb’s law Eq. (2.3) for humans.
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The only study [133] which reported the measure in humans of the
functional metabolic–vascular response by means of three independent
fMRI techniques suggests a great deal of caution when applying Grubb’s
law. The authors performed an experiment where, beside BOLD con-
trast, two perfusion methods were utilized to single out the changes
in CBF and CBV. In comparing the experimentally measured CBV
with the value calculated through Grubb’s law, the authors found that
Eq. (2.3) systematically results in CBV underestimation, which, in turn,
may give rise to systematic errors in the estimated CMRO2 . This non–
correspondence could arise from the fact that the relationship between
CBF and CBV was established by Grubb et al. [103] by means of PET
for stationary hypercapnic stimuli in monkeys, whereas it could be ar-
gued that the human neuronal activation is notably different from this
case. Supporting this idea, Hyder et al. [134] found to be 0.1 in the rat
cortex for a wide range of activity, while Wu et al. [135] showed this
parameter to be largely region specific.
The critical role of CBV has also been emphasized by Lee et al.
[136]. The authors highlighted that separating the contribution of blood
volume from the arterial and venous sides of the vascular system is cru-
cial for the quantification of the BOLD signal. In contrast, the NMR or
PET methodologies use intravascular contrast agents which are capable
of revealing the total CBV alone. The authors utilized a method for the
regional measurement of arterial and venous CBV fractions which was
suggested by Duong and Kim [137]. This strategy consisted of the use of
diffusion–weighted 19F–NMR with the intravascular administration of
PerFluoroCarbon (PFC); such an agent possesses two pseudo–diffusion
constants, one reflecting more oxygenated blood, and the other reflect-
ing less oxygenated blood. This characteristic allows for the provision of
quantitative information about the compartment distribution by means
of parameters obtained in the bi–exponential fitting. Lee et al. [136] in-
vestigated in rats the modulation of arterial and venous CBV during
hypercapnia–induced CBF changes. They found that the arterial CBV
changes were about 5 times larger than venous CBV changes, and that
the relative CBV changes in venous blood was 50% of the relative CBV
changes in the entire blood. Such a finding contrasts from what suggested
by Mandeville et al. [104, 105] and by Buxton et al. [101] in the Balloon
model, who assumed that changes in venous blood volume dominate the
total blood volume increases. The overestimation of CBV changes con-
tributing to the BOLD signal (which corresponds to an underestimation
of CMRO2) can be solved by halving the measured total CBV changes.
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The results obtained by Lee et al. [136], nevertheless, cannot directly be
applied on humans, because they referred to anesthetized rats, whose
blood flow velocities are very different from the case of conscious hu-
mans. Even if the study by Lee et al. has the drawback of not providing
spatially resolved information, it has however proved of great interest
insofar as it focused on the poorly discussed role of CBV in the deter-
mination of the BOLD signal. In order to address the issue of region
specificity, a recent non–invasive MRI approach has been proposed to
estimate the cerebral and arterial blood volumes separately in humans
[138], but at the moment it has not been applied to functional studies,
nor validated.
As a final consideration, it must be recalled that the increase in
blood volume has been here assumed merely to result in a BOLD sig-
nal decrease. This assumption is not necessarily true at 1.5 T, where
the contribution of intravascular spins is predominant, and renders the
effect of CBV more complex. A global model of the phenomenon, more
exhaustive from a physiological and physical point of view, continues to
be provided.
2.4 Physiological indications from optical methods
Several optical methodologies [139, 140] are currently used to investigate
the relationship between blood flow and oxygen metabolism changes.
These techniques are able to measure the changes in oxyhemoglobin
(HbO2) and dHb contents, as well as the changes in cerebral blood vol-
ume and in the redox status of cytochrome oxidase. Optical methods
offer the great advantage of having very high temporal resolution, thus
allowing key dynamical information to be obtained. The so–called ‘fast
response’ was reported for the first time by Grinvald and colleagues
[6, 141], who utilized in vivo intrinsic optical signals reflected from the
exposed visual cat cortex. They revealed an initial increase in dHb af-
ter a brief stimulation, around 2.5 s after the task onset, followed by
a later and more pronounced decrease about 6 s after the task onset
(‘slow-response’). This dynamics has been interpreted to correspond to
the biphasic behavior of the BOLD signal observed at a high field [23–
28]. The existence of an early deoxygenation phase, nonetheless, remains
controversial in both the optical imaging and fMRI literature, because
this phase is not always found (as an example of this, NMR studies were
unable to detect the initial dip in the rat primary sensory cortex even at
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very high magnetic fields [142]), and because it can be eventually justi-
fied in different ways. It is interesting to note that none of the published
optical studies showed a decrease in oxyhemoglobin concomitant with
the reported initial increase in dHb content. Instead, a typical finding
is that oxyhemoglobin remains constant while the dHb begins to rise.
This observation supports the idea that the fast response might result
from a complex interplay of changes in CBV and OEF.
On the other hand, a number of critical assumptions must be made
in order to interpret quantitatively the optical signal in terms of oxy-
gen metabolism changes. Lindauer et al. [143] did not reveal any dHb
increase, and they motivated this result showing how a not correct analy-
sis of the optical path length can lead to an artifactual initial increase.
Nonetheless, Jones et al. [144] further spark the controversy, because
they found a reproducible initial dHb increase (consistent with earlier
works of this group [145]) by using the same rat model and the same
sophisticated path length analysis utilized by of Lindauer et al. [143].
The dynamical data of Jones et al. [144] were also used by Mayhew et
al. [146] in order to explore the validity of the oxygen limitation model
in the original form formulated by Buxton and Frank [101, 102], and
in the extended form formulated by Hyder et al. [147], who included
a variable oxygen diffusivity proportional to CBF. Mayhew et al. [146]
concluded that neither of them gave a particularly good account of the
data, and suggested that a more convincing model should consider a
non–null tissue oxygen concentration (in the oxygen limitation model,
this parameter was implicitly supposed null). According to the authors,
the tissue level of oxygen is moderated by changes linked to increased
metabolic demand. The presence of O2 in the tissue could be fundamen-
tal in explaining the initial dip variability. In fact Mayhew et al. [146]
reported that hyper-oxygenation reduces or eliminates the initial dip,
and, on the other hand, Lindauer et al. [143] (who found no initial dip)
used a high concentration of inspired O2. Along the lines stretched by
Mayhew et al. [146], Buxton [148] has revised the oxygenation limita-
tion model, by including a buffer of available oxygen and the presence
of O2 diffusion from tissue to capillaries. In this scenario, CBF would be
regulated in order to maintain the buffer of oxygen at a constant level.
In order to overcome the ambiguities of earlier optical studies, Van-
zetta and Grinvald [149] used an optical technique based on the phospho-
rescence decay of an oxygen tension–sensitive phosphorescent intravas-
cular probe. A longer phosphorescence life–time implies a decrease in
the microvascular pO2, and implies a decrease in free oxygen concen-
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tration. The authors found an initial dip in the average pO2 of blood,
which, again, has been linked to an increased consumption of oxygen not
compensated by blood flow. Unfortunately, Lindauer et al. [143] utilized
also the technique of Grinvald et al., and they found no initial dip. The
authors interpreted the results by Vanzetta and Grinvald, again, as a
processing artefact, which derived from the assumption of an oversim-
plified single well–mixed compartment with a uniform pO2.
All the above–mentioned optical studies utilized a surface optical
mapping of exposed animal brain, and, given their invasiveness, they are
not suited for application to humans. In contrast, it has been recently
shown that near–infrared light can penetrate biological tissue, thus al-
lowing the non–invasive assessment of brain activity through the intact
skull. By means of single–site Near InfraRed Spectroscopy (NIRS), the
increase of haemoglobin oxygenation about 5÷ 6 s after the task onset
[6] was confirmed in healthy human subjects during a variety of stim-
ulation paradigms, such as visual [139], motor [150] and cognitive [139]
tasks.
CHAPTER 3
Metabolites at Work: in vivo Nuclear Magnetic
Resonance Spectroscopy
3.1 Quantitative Nuclear Magnetic Resonance Spectro-
scopy
1H–MRS is currently being investigated as an additional noninvasive
tool to monitor the cerebral metabolic profile in the living human brain
and to provide more insights into in vivo neurochemistry. This offers
the opportunity for studying normal metabolism and development, the
aging processes and the pathophysiology in a variety of diseases, as well
as to monitor metabolite level changes over time due to disease progres-
sion or pharmacological therapies. Nevertheless, quantitation, as well as
automation, still remains the fundamental requirement to make MRS
an indispensable tool in human neuroscience. Automated pattern recog-
nition analysis of spectra will be the fundamental objective for classifi-
cation between normal and pathological areas.
As known, proton–containing metabolites and cellular compounds
are restricted to a narrow chemical shift range of about 4 ppm. Conven-
tional 1H spectra of human brain tissue, typically obtained from 2−20 ml
Volume Of Interest (VOI) in different locations in cortical gray and white
matter, basal ganglia, and cerebellum, contain signals arising from ap-
proximately twenty low molecular weight metabolites. The use of shorter
TE times in clinical investigations, reducing signal attenuation due to
spin–spin relaxation and scalar coupling, makes it possible the detection
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of glutamate, γ–AminoButyric Acid (GABA), myo–inositol, and gluta-
mine with minimal distortions due to J–coupling [31, 151–154]. However,
only relatively few of them may be unambiguously identified or even
quantified at clinical magnetic field strengths, due to the complexity of
the spectra and the unpredictable forms of the line shape and baseline.
Actually, the strong coupling between proton spins of these metabolites
gives rise to complex multiplet spectra, with extensive resonance over-
lapping, still further complicated by the presence of broad signals from
macromolecules and lipids, at least at field strengths acceptable for clin-
ical use. Glutamate and glutamine, for example, split into multiplets in
the spectrum due to their chemical structures, overlap to a large extent
in their chemical shift range and both show overlapping contributions
from GABA. Furthermore the number of scans is necessarily limited in
order to keep short acquisition times. Many of these difficulties are over-
come at fields higher than those typically used in clinics; indeed, at very
high fields the SNR increases and partially overlapping multiplets are
better resolved, despite the shorter T2 of metabolites, due to the fact
that the overall signal width of multiplets is dominated by homonuclear
J–coupling, which does not depend on B0. For example, only the singlet
component at 3.57 ppm of myo–inositol, which resonates at four chemi-
cal shift positions, is detectable at 1.5 T, whereas at 3 T this resonance is
resolved into its components at 3.55 ppm and 3.61 ppm [155], and at 7 T
its characteristic spectral pattern is completely discernible [152] with a
significant improvement of the quantification precision, reproducibility
and detection sensitivity of this polyol.
Another factor susceptible to affect the metabolite concentration es-
timates is ascribable to the different T1 values between metabolites in
the same or different tissues. Actually, in most studies, metabolite peak
areas are heavily T1–weighted because of the short TRs usually imposed
by time constraints in clinical studies.
Different procedures are reported in literature in either frequency or
time domain [156, 157]. for the spectral quantitative evaluation. In the
latest years, time domain processing methods gained great attention
because of their several advantages: they require less or any invasive
pre–processing, and they are intrinsically free either from spectral dis-
tortion due to non ideal Free Induction Decays (FIDs) (e.g. for truncated
points), or from baseline problems due to fast decaying signals or im-
perfect water suppression [158]. On the other hand, in the frequency
domain methods, the visual interpretation of the measured signal and
the quality assessment of the fitting results are better achieved, and the
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frequency–selective analysis is straightforward.
Several ‘black-box’ time–domain quantification methods are avail-
able [157, 159, 160]. They require minimal user interaction and exper-
tise (hence the name of the procedure), but results obtained from the
fitting, especially in low SNR spectra, often lack physical meaning. Any-
way, such kind of methods produce results with high computational
efficiency and without any need for starting values; besides, they can
model complex line shapes by the superimposition of Lorenzian curves.
All these characteristics allow their utilization in pre–processing steps,
such as residual water suppression, and in obtaining starting values for
algorithms that exploit prior knowledge.
The possibility of easily incorporating large amount of prior knowl-
edge, typical of the model fitting methods, has a particular interest in
the in vivo brain chemistry investigation. Model fitting methods are
equally well developed in time–domain and frequency–domain; the a
priori knowledge of the spectral pattern of the individual metabolites
can be obtained from simulations of model spectra [161] or directly by
the effective measurements of model spectra in single solutions [162]
NMR investigated in the same experimental conditions as the in vivo
spectra. In this latter case, the two main approaches build up the fitting
model either from the linear combination in the frequency–domain of
the in vitro model spectra [163, 164], or from the superimposition of
damped waveforms (generally sinusoids) in the time–domain, where the
parameters which determine the spectral line shapes (i.e., amplitudes,
linewidth, relative phases, and frequencies) are optimized for the phan-
tom solutions [158, 165]. In both cases the estimates are obtained by
minimizing the squared difference between the experimental data and
the model.
To date, the software packages more commonly used for quantitation
are AMARES [165], a non–linear least square fitting algorithm operat-
ing in the time domain as implemented in the MRUI package [166], and
LCModel [163], which analyzes an in vivo spectrum as a linear combi-
nation of a basis set of model in vitro spectra from individual metabo-
lite solutions, thus exploiting the full spectroscopic information of each
metabolite and not isolated resonances.
In this Section we describe our approach to the quantitation of in
vivo short–TE spectra of metabolites in the cerebellum of normal sub-
jects by employing LCModel fitting and using relaxation time correction.
A set of in vitro spectra of known metabolites was prepared and used
as basis functions. We also evaluated the influence of including a macro-
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molecular baseline spectrum into the basis set. Furthermore, different
line broadenings and noise conditions have been simulated in order to
determine the dependence of metabolite estimates on non ideal linewidth
and different SNR experimental conditions.
3.1.1 Methods
Sample preparation
A set of individual metabolite samples of L–alanine (Ala), Aspartate
(Asp), Choline (Cho), Creatine (Cr), γ–AminoButyric Acid (GABA),
D–glucose (Glc), L–glutamine (Gln), L–glutamate (Glu), Myo–inositol
(mI), Lactate (Lac), N–acetyl–L–aspartate (NAA), Taurine (Tau) and
Glycine (Gly), were dissolved in a pH 7.1 buffer solution of KH2PO4 +
K2HPO4 to a concentration of 50−200 mM as suggested in the LCModel
user’s manual [167]. When required, pH value was adjusted using NaOH
and HCl and set to pH 7.1 ± 0.1. Chemical shifts were referenced to
the methyl signal of 2,2–dimethyl–2–silapentane–5–sulfonate (DSS) at
2 mM concentration. Also Na formate was added, to a concentration
of 200 mM. A mixture solution containing Cho, Cr, GABA, Glc, Gln,
Glu, mI, Lac, NAA and Tau was then prepared at concentration val-
ues similar to average brain values [168]. A small amount of sodium
azide (0.10%) was added as germicide to each preparation. Polypropy-
lene bottles (volume 1 l) were used for storage and data acquisition.
Samples were positioned with their symmetry axis parallel to the B0
field.
The individual metabolite data (except Gly) were then used to ob-
tain the basis spectra for the LCModel quantitation [167]. In brief, spec-
tra were automatically corrected for eddy–currents, phased, referenced
and scaled by using the singlet of DSS at 0 ppm and of Na formate
at 8.44 ppm. Scyllo–inositol (Scyllo) and N–acetyl–L–aspartylglutamate
(NAAG) were simulated in the basis by opportunely shifting and scaling
the spectra of Gly and NAA, respectively.
Subjects
Seven healthy volunteers (3 women and 4 men, age 28±9 yr, mean±SD)
were recruited for this study. Two or three spectra were acquired on each
participant. Informed consent was obtained from all of them.
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Data acquisition
All examinations were performed on a 1.5 T whole–body system (NV/i,
General Electric Medical Systems, Milwaukee, WI, USA) using a stan-
dard birdcage head coil. For the in vivo acquisitions, a Point–RESolved
Spectroscopy (PRESS) localization sequence was used with TR/TE =
1500/30 ms, 128 FID averages and 16 unsuppressed water FID averages,
sweep width = 2.5 kHz , data size = 2k points. The voxel size was set
to 2.0 × 2.0 × 1.5 cm3 and was centered in the cerebellar area of the
subjects.
For the in vitro acquisitions the same sequence was utilized, but with
TR = 10000 ms. The long TR was chosen to avoid partial saturation
effects. The voxel was 2.0 × 2.0 × 2.0 cm3 and was put in the center of
the bottle. In vitro spectra were acquired all in the same experimental
session.
Data simulation
In order to test the reliability of LCModel quantitation in non ideal
conditions, spectra with low SNR and broad spectral signals (mimick-
ing poor shimming, subject movements, spectrometer instability) were
generated from the original spectra.
The in vivo spectra underwent a preliminary analysis with custom
routines written in Matlab [169]. Spectra were eddy–current corrected by
means of water–unsuppressed data [170]. When required, manual phas-
ing was performed. Then, the Cr linewidth and the SNR were obtained
for each spectrum. Linewidth was measured, as usual, as FWHM, and
the SNR was defined as the ratio between Cr amplitude in the frequency
spectrum and the standard deviation of the last 100 points of the FID.
FWHM and SNR were checked for outliers (defined as values different
from the mean value more than 1.5 SD . Spectra had outliers neither
for FWHM nor for SNR values.
Two sets of spectra with broadened linewidth were obtained with
a gaussian line broadening of 1 and 2 Hz applied to each spectrum.
Subsequently, two levels of SNR were simulated for each spectrum of
the three sets (the original one and the two line–broadened). Spectra
with SNR values equal to a half and a fourth with respect to the original
spectrum were obtained by adding white, uncorrelated gaussian noises,
with appropriate standard deviation, to real and imaginary parts of
FIDs. Therefore, for each spectrum, eight spectra with different levels
of noise and line broadening were simulated.
48 Chapter 3
Data analysis
All the spectra were analyzed with LCModel, version 6.1–0 under Linux
platform [163] in the spectral window 4.1 − 0.2 ppm, with prior eddy–
current correction by means of water–unsuppressed data [170] and the
basis spectra obtained as described above. The water–unsuppressed data
were utilized also for scaling the spectral amplitude to the mean water
content of grey matter, assumed to be 41.7 M. Analysis was performed
both with and without including simulated broad signals from macro-
molecules and lipids into the basis set.
For the absolute quantification, relaxation times losses were taken
into account by considering the T1 and T2 values of the main substances
under investigation in the cerebellum. The following corrections were
applied, where signal intensities were weighted on the basis of TE and
TR values employed in the in vivo and in vitro experiments:
(3.1) Ccorri = C
uncorr
i
fT2i
fT2H2O
·
fT1H2O
fT1i
where Ccorri and C
uncorr
i are the absolute concentrations of metabolite
i corrected and uncorrected, respectively, for relaxation effects,
(3.2) fT2 = e
TE

1
Tvivo2
−
1
Tvitro2

is the correction for transverse relaxation in the PRESS sequence, and
(3.3) fT1 =
1− e
−
TR
Tvivo1
1− e
−
TR
Tvitro1
is the correction factor due to longitudinal relaxation to be considered
for the same pulse sequence. In practice, as the basis spectra were ac-
quired in fully relaxed conditions, the denominator of Eq. (3.3) was
approximated to 1.
Furthermore, the T2 correction actually concerns a second order ef-
fect; as can be seen from Eq. (3.1) and following, the correction is re-
lated to the ratio between the correction factors of water and a specific
metabolite, and each correction factor is related to the variation of re-
laxivity between in vitro and in vivo conditions. This is due to the fact
that the quantitation method itself automatically accounts for in vitro
transversal relaxivity, as it fits the spectrum with in vitro templates.
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For this reason, the estimate of T2 is not critical; therefore cerebellar T2
values known from literature were employed for the in vivo correction
factor [171], while the in vitro T2 values were roughly estimated from the
spectral linewidth of singlets. The concentrations of metabolites, whose
in vivo T2 values are not known from the literature, are not corrected
for relaxivity.
The reliability of each single concentration estimate was evaluated by
the Crame´r–Rao Lower Bounds (CRLB) [172], provided by the program.
We did not consider any correction for cerebrospinal fluid contributions
to the volume of interest selected for the in vivo spectroscopy investi-
gations, thus assuming that no significant partial volume effects were
present.
The absolute concentration estimates are expressed as intersubject
averages. As a different number of spectra were acquired for each subject,
the evaluations were opportunely weighted, in order to obtain the same
weight for each subject in each metabolite quantitation. We set our
selection criterion for estimates of acceptable reliability to a value of
CRLB ≤ 20%.
In most clinical investigations, the changes in metabolite values are
often evaluated in terms of a comparison of their relative ratios to crea-
tine with those of normal subjects, although, various pathological states
may cause a variability of this metabolite. Moreover, the corrections for
relaxation effects are ignored anyway due to the uncertainties in the
relaxation times of the various pathologies. Since concentration ratios
are less sensitive than absolute concentration to relaxation and partial
volume averaging, we also determined metabolite concentrations by as-
suming creatine as an internal reference.
The reproducibility of metabolite quantitation corresponding to dif-
ferent SNR and line broadening was evaluated in a similar way. As the
line broadening affects all spectral peaks, the expected value of T2 was
not modified in the quantitation. Indeed, the fitting lineshape parame-
ters account for the increased transversal relaxation rates from in vitro to
in vivo conditions, and a modification of the expected T2 is only required
when metabolites experience differential T2 variation [163]. Relaxivity
was not taken into account in this part of the study. The reliability of
each single quantification was evaluated also in this case by the CRLB
values. However, due to the specific aim of this part of the study, all
successful quantifications were included in the averages, and not only
values with CRLB ≤ 20%.
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Figure 3.1: A representative in vivo spectrum (grey shadowed) with the
various simulations. Each horizontal step corresponds to halving the SNR,
each vertical step corresponds to a line broadening of 1 Hz. Vertical scale
is expressed in the same arbitrary units for all spectra. The spectral win-
dow is the same as the one utilized in the quantitation (4.1 − 0.2 ppm).
From [173].
3.1.2 Results
A representative spectrum with different line broadening and/or noise
level simulations is shown in Fig. 3.1. The original spectrum shows, as
expected, large signals overlaps, broad signals ascribable to macromole-
cules and lipids, and the typical SNR and spectral resolution conditions
achievable in a clinical environment. The simulated spectra correspond
to progressively deteriorated noise and linewidth conditions.
The estimates of absolute concentrations for the main metabolites in
the cerebellum are reported in Table 3.1. As described in Methods, data
showing CRLB > 20% were excluded from this specific part of the study,
in order to obtain the most reliable estimates of metabolite concentra-
tions in the cerebellum of healthy subjects. In Fig. 3.2 is reported the
number of spectra that, in correspondence of a given level of SNR and
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Table 3.1: Absolute concentrations of main cerebral metabolites in the
cerebellum.
Metabolite Concentration without MM Concentration with MM
Absolute (mM) /Cr Absolute (mM) /Cr
a)
Cho 2.05± 0.08 0.24 2.19± 0.09 0.24
Cr 8.6± 0.3 1 9.1± 0.3 1
mI 6.9± 0.4 0.80 6.3± 0.4 0.69
NAA 8.0± 0.2 0.92 8.0± 0.3 0.88
b)
Gln – – 6.6± 0.4 1.0
Glu 7.4± 0.3 1.1 7.0± 0.4 1.1
NAA+NAAG 7.5± 0.2 1.2 6.9± 0.2 1.1
Glx 12.9± 0.7 2.0 12.2± 0.5 1.9
In section a) the absolute concentrations of the main cerebellar metabolites,
corrected for relaxation effects, and their respective ratios to Cr concentration
are reported. Section b) reports the absolute concentrations and Cr ratios of
other cerebellar metabolites, which have been quantified but not corrected for
T1 and T2 effects. Values are expressed as mean±SEM; the uncertainty on T1
and T2 is not taken into account. The concentrations were evaluated without
including the broad signals of MacroMolecules (MM), (left side), and in their
presence (right side); for details see the Methods. From [173].
line broadening, had the accepted reliability (i.e. CRLB ≤ 20%) for the
metabolites under examination. As expected, this number decreases with
reduced SNR levels. Cho, Cr and NAA+NAAG quantitation does not
give any problem, even in the worst experimental conditions. NAA and
mI quantification are still reliable with half SNR, while the results be-
come unstable at the lower level of simulated SNR. Quantitation of these
two metabolites is also slightly affected by spectral resolution. A further
obvious result is that the inclusion of macromolecular baseline modifies
the number of ‘reliable’ quantifications of the sum of L–glutamate and
L–glutamine (Glx). When quantitating Glx, lower CRLB values are ob-
tained if MM are included in the basis set, and the quantitation seems
to become even more reliable by decreasing SNR and spectral resolution
[173]. This feature will be discussed later.
In Fig. 3.3 is reported the relative variation of concentration es-
timates in correspondence of different spectra quality conditions; in
Fig. 3.4 the LCModel fitting of a representative spectrum in the four
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Figure 3.2: a) Number of spectra with CRLB ≤ 20% for each metabolite,
without including MM into the basis set. The upper row corresponds to
spectra with the original SNR, in the successive rows the results for reduced
SNR are reported. In each panel, the left frame shows the results relative
to spectra without any line broadening, the middle and right frames report
the results for increasing line broadening. b) The same of a), but including
MM in the quantitations. From [? ].
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extreme conditions of SNR and line broadening is reported.
The metabolite concentrations found in the cerebellum are compat-
ible with the values known from the literature, relative to brain tissue
[168] and, when available, to cerebellum itself. In particular, the values
we found for NAA, Cr and Cho are quite similar to those reported by
Hennig et al. [174].
The level of glutamine we obtained was high if compared to the
values observed in the other brain regions [175, 176]. To our knowledge,
no other in vivo evaluation of Gln in the human cerebellum is available
from literature, while a value of 4.83± 0.32 mM has been measured on
ex vivo extracts obtained from various brain regions [176], by proton
MRS. Furthermore, our result can be slightly underestimated, due to
the lack of correction on T2 and T1 effects.
Our results are not directly comparable with those of Kanowski et al.
[177], owing to the inherent differences between fully simulated spectra,
utilized in [177], and our experimental approach, based on simulated
deterioration of in vivo spectra. Indeed, the study of Kanowski et al.
investigated the SNR influence in a range of values higher than we did.
This can explain why it was therein found that the reduction of SNR
mainly increases the uncertainty in quantitation, with few effects on
the absolute values of concentrations, while in our study we observed
a noticeable variation of the quantitative values in correspondence of
reduced SNR, especially for some metabolites.
In this study, the model fitting we used comprised various metabo-
lites whose exact quantitation is almost impossible at 1.5 T. On the
other hand, the standard LCModel fitting routine comprises an even
larger number of metabolites in the basis set. The aim of this inclusion
is essentially to improve the fitting of more prominent signals, by remov-
ing, at least partially, some overlapping components. Nonetheless, it is
not clear if this approach has positive effects or even makes the quanti-
tation of the main metabolites less reliable. While the inclusion in the
model of a larger number of metabolites produces undoubtedly a more
accurate overall fitting, the overfitting of the data can easily enlarge the
uncertainty of the measurements [178].
The number of data with CRLB ≤ 20% reported in Fig. 3.2 confirms
that the inclusion in the fitting of the free parameters related to the 13
simulated MM spectra has great influence on the quantitation of several
metabolites. As already observed, Glx concentrations showed increased
CRLB values without MM in the basis set (i.e., the number of quantita-
tions with CRLB ≤ 20% is reduced). This unexpected feature, examined
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Figure 3.3: Relative variation of concentration estimates of some meta-
bolites in correspondence of different SNR and spectral resolution condi-
tions, referred to the quantitative data obtained from the original spectra
without including the MM baseline in the model. In each panel the quan-
titations without and with MM in the model are reported in the left and
in the right frame, respectively. In correspondence of each line broaden-
ing, the colors represent different levels of simulated SNR (red: original
SNR, green: SNR halved, blue: SNR reduced to 25%. Relaxation effects
are in this context not influent and are not taken into account. Values are
expressed as mean± SD. From [? ].
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Figure 3.4: A representative in vivo spectrum and overlay of LCModel fit-
ted spectrum, with different simulations. Only extreme cases are reported,
i.e. higher/lower SNR and no/maximum line broadening. On top of each
spectrum is reported the residue of the quantitation. The same vertical
scale, in arbitrary units, is adopted for all spectra. a) Spectra quanti-
fied without MM inclusion in the basis. b) Spectra quantified with MM
simulation in the basis set. From left to right: original in vivo spectrum,
original spectrum with maximum level of noise added, original spectrum
with maximum line broadening applied, original spectrum with maximum
line broadening applied and maximum noise added. From [? ].
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together with the results of Fig. 3.3 and 3.4, suggests that, in absence
of MM from the basis, the degrees of freedom related to Glx quantita-
tion are exploited by the algorithm to fit baseline components instead of
the metabolites itself. Actually, such hypothesis is strengthened by the
further decrease of CRLBs of Glx when noise and line broadening are
increased, and thus the metabolites progressively loss their line shapes.
It has been observed that even a subtle change in the basis compo-
sition can affect the concentration estimates of almost all metabolites
under consideration. In particular, that holds true if a metabolite, whose
spectrum shows large overlapping with other basis spectra, is added or
removed from the basis set [178]. The LCModel fitting results, in terms
of concentrations and of baseline smoothness, are also strongly influ-
enced by the inclusion of MM in the model [178]. Our results indicate
a dependence of these effects on the SNR of the spectra. Indeed, it is
apparent from Fig. 3.3 a marked influence of the noise level on some es-
timated concentrations. This effect is less pronounced if the MM signal
is included in the model fitting.
The regularization algorithm that estimates the spectral baseline in
LCModel can account for several unwanted signal features, like distor-
tion due to susceptibility or uncorrected eddy–currents [164]. In partic-
ular, it has been shown its capability to reproduce the MM broad signal,
without any a priori knowledge, when MM measured or simulated com-
ponents are not included in the fitting [179].
Fig. 3.4 clearly shows that, when the MM are included in the mo-
del, the smoothness of the spline baseline is quite modified at low SNR,
while this effect is greatly reduced by removing the MM from the model.
The residue remains essentially unchanged in both conditions, while the
metabolite quantitation remarkably changes, probably due to the change
of the baseline estimate. If we assume the concentrations measured on
the original spectra as correct, this result, considered with those re-
ported in Fig. 3.3, suggests that, at very low SNR, the quantitation is
enhanced by including the MM in the basis set, even though it produces
a modification in the estimated baseline.
It is well known from the literature [177] that SNR and spectral res-
olution influences the SD of quantitative analysis of proton MR spectra,
and thus the sensibility of the technique. Our study underlined that dif-
ferent levels of SNR and spectral resolution can affect, in extreme cases,
also the mean value of multiple spectra (i.e., the precision of the quanti-
tation). Thus, special attention should be paid when spectra of different
quality are examined in the same study.
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3.2 An application: cerebellar alterations in migraine
In this Section, our investigation exploiting the time domain model fit-
ting approach in the characterization of a particular form of migraine
called ‘with aura’ is reported.
Migraine is a neurovascular disorder that affects a relevant amount
of the general population (12% of the males and 24% of the females)
[180]; up to now, there are not available specific biochemical markers for
this pathology and the diagnostic methodology routinely used is entirely
based on medical history and clinical examination.
According to the International Headache Society classification [181],
it is possible to categorize migraine into two main types: Migraine With-
Out Aura (MWOA) and Migraine With Aura (MWA). The latter form
features a transient focal neurological symptom, generally visual, pre-
ceding the attack itself. Although there are conflicting opinions on the
familial inheritance of this pathology, there is a rare form of migraine
with aura known as familial hemiplegic migraine that is linked to a given
gene (CACNA1A), coding for the pore–forming subunit of voltage–gated
P/Q Ca2+ channels. This gene might also be implied in others forms of
MWA, more commonly found, and it is particularly expressed in the
cerebellum [182]. Specifically, our aim is to assess by short TE proton
spectroscopy possible alterations in the main metabolite concentrations
that may be the expression of some metabolic dysfunction characterizing
this form of migraine. The etiology is still unknown. Early investigations
carried out with 31P spectroscopy have already evidenced defective brain
and muscle energy metabolism in patients affected with migraine with
different degrees of severity during the interictal period [183].
3.2.1 Methods
Subjects
Prior to investigations, all subjects gave their written informed consent.
Eight patients, (6 women and 2 men, age 28±11 yr, mean±SD) suffering
from migraine with auras characterized by neurological features, such
as somatosensory, motor and/or language impairment, in addition to
visual symptoms, and seven healthy volunteers (3 women and 4 men,
age 28±9 yr, mean±SD) were included in the study. Two or tree spectra
were acquired on each subject.
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Phantom preparation
Cr, mI, Glu, Gln, Cho, Tau, Lac, NAA, and GABA were dissolved sep-
arately in a buffer solution of KH2PO4 + K2HPO4 to a concentration
of 50 mM. The solution pH was adjusted using NaOH and HCl and
set to pH 7.0 ± 0.1. All chemical shifts were referenced to the methyl
signal of DSS at low concentration. Each solution was transferred into
100 ml phantoms. Mixture solutions of mI, Cho, Glu, Gln, Lac, NAA,
and GABA were prepared in the same way as the individual solutions
at two different concentration values, 50 mM and to a concentration 10
times bigger than brain average values [168]. A small amount of sodium
azide (0.10%) was added to each preparation as bacteriostatic. The in
vitro data were used for the prior knowledge template.
Data acquisition
All measurements were performed with a 1.5 T whole-body system
(NV/i, General Electric Medical Systems, Milwaukee, WI, USA) in the
MR imaging and spectroscopy unit of IRCSS Neuromed (Pozzilli, IS,
Italy). In vivo proton spectra were acquired with a standard birdcage
head coil using a single-voxel PRESS sequence (TR/TE = 1500/30 ms).
The voxel size was set to 2.0× 2.0× 1.5 cm3 (6 ml) and centered in the
cerebellar hemisphere on the dominant side. Typical acquisition para-
meters were: 128 FID averages and 16 unsuppressed water FID averages,
sweep width = 2.5 kHz , data size = 2k points. 1H MR spectra were ac-
quired on patients during their interictal period. In vitro proton spectra
were acquired with the same experimental procedures.
Data analysis
All spectra were analyzed with jMRUI software [184]. All data were
phase and eddy–current corrected by means of water–unsuppressed data
[170]. The residual water was finally removed by the Hankel Lanc-
zos Singular Values Decomposition (HLSVD) filter application. Single
metabolite spectra were analyzed by AMARES [165, 185], a non–linear
least square fitting algorithm operating in the time domain, included in
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jMRUI software. AMARES utilizes the following model function:
(3.4) yn =
K∑
k=1
ak exp(−dk(1− gk + gktn)tn) exp(ı2pifktn + ıφk) + en
(n = 0, 1, ..., N − 1)
where the summation is extended to K resonances, ak represents the
peak amplitude and is proportional to the number of protons partici-
pating to the resonance of frequency fk , phase φk and damping dk , and
gk allows the choice between pure Lorenzian (gk = 0) or pure Gaussian
(gk = 1) line shape, separately for each peak. Finally, tn is the (dis-
crete) sampling time and en is the complex noise, assumed to be white
Gaussian.
The spectral modelling from phantom solutions was performed by
introducing the prior information on the number of protons participat-
ing to each resonance and on J–couplings, phases and the structure of
multiplets when these parameters were known, and leaving them uncon-
strained in the other cases [168]. Damping ratios, frequencies and phase
differences were derived from the fits and referred to the most prominent
metabolite peak with regards to damping and frequency and to water
peak in the case of phase, and then utilized in the analysis of the in vivo
spectra.
Metabolite concentrations from the in vivo control spectra were eval-
uated by considering the total creatine or choline or water as internal
reference. The following expression was used:
(3.5)
ci
cref
=
Ai
Aref
nref
ni
where c is the concentration, A is the peak amplitude and n the number
of protons contributing to the resonance peak identified by the subscript
i for the metabolite under examination or ref for an internal reference
molecule (total Cr, Cho or water).
We didn’t apply any correction either for the differential T2 atten-
uation and T1 related partial saturation, or for partial volume effects.
Actually, this procedure can lead to concentration ratios between meta-
bolites partially inaccurate, but our approach relies on spectra acquired
on the same district and in similar experimental conditions, so these
factors equally affect controls and patients and do not influence the sta-
tistical distribution of measurement. However, we avoided the evaluation
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of absolute metabolite concentrations.
The t–test for unpaired data was used to assess significant differ-
ences (p < 0.05) of the metabolite ratios between the patients and their
age-matched controls. A non–parametric test for unpaired data (Mann–
Whitney test) was also applied to assess differences of the metabolite
ratios between the two groups.
3.2.2 Results
Fig. 3.5 shows the location of the volume of interest in the cerebellar area
with two examples of spectra from a given patient and his age–matched
control. The corresponding spectral fittings are also reported.
Table 3.2 contains the results of the metabolite ratios under inves-
tigation. Specifically, means, SD, Coefficient of Variation (CV), and p–
values of the metabolite ratios relative to NAA, Cr and Cho are shown.
As evidenced by the reported data, no changes were detected in the
Cr/NAA ratios relative to the two groups of subjects, thus suggesting
that Cr and NAA concentrations keep quite stable in this clinical sit-
uation. Conversely, Cho/Cr and Cho/NAA ratios in the patients are
highly significantly decreased if compared to the corresponding values
in the healthy group. The experimental data revealed significance also
for mI/Cr and mI/NAA ratios. In particular, they resulted decreased in
the patients group. In Fig. 3.6 are depicted the ratios of the metabolites
values in the cerebellum obtained from the eight patients suffering from
migraine and the normal subjects with the corresponding significance
levels.
Our results suggest that subjects suffering from migraine feature
alterations in the concentrations of myo–inositol and choline. No statis-
tically significant difference was observed between the two groups when
comparing the same metabolites of interest referred to the total amount
of unsuppressed water in the volume of interest [186].
Myo–inositol is at the center of a complex metabolite pathway involv-
ing among other products inositol phospholipids and inositol phosphates
which have well established functions in signal transduction and in Ca2+
homeostasis in the CNS and non–neural tissues. Actually, some forms
of migraine with aura might be related to some metabolic dysfunction
Ca2+ channels related [187, 188].
Choline plays an important role in the synthesis of the major con-
stituent of membranes, phosphatidylcholine, and of the neurotransmit-
ter acetylcholine. The choline signal in proton spectra, referenced at
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Figure 3.5: Location of the VOI centered in the cerebellar hemisphere on
the dominant side. b) Proton spectrum from the volume above relative to
a given patient and c) the spectral evaluation of the data reported in b)
following the quantification procedure. d) and e) The same as in b) and c)
but relative to a normal volunteer investigated in the same experimental
conditions. From [186].
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Figure 3.6: Metabolite ratios in the cerebellum obtained from eight pa-
tients suffering from migraine and seven normal subjects referred to as
controls. Close symbol shows the mean and vertical bars are equal to
±1 SD. Spectra from patients were obtained during their interictal period.
N.S.: not statistically significant.. From [186].
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Table 3.2: Metabolite ratios relative to NAA, Cr and Cho in controls and
patients.
Cr/NAA Cho/NAA mI/NAA
Mean SD CV p Mean SD CV p Mean SD CV p
0.868 0.011 13% 0.257 0.029 11% 0.71 0.11 15%
0.8 0.005 0.04
0.876 0.013 15% 0.222 0.034 15% 0.60 0.10 17%
Cho/Cr mI/Cr
Mean SD CV p Mean SD CV p
0.291 0.026 9% 0.802 0.089 11%
0.003 0.04
0.256 0.033 13% 0.742 0.081 11%
mI/Cho
Mean SD CV p
2.79 0.48 17%
0.5
2.91 0.48 16%
The table reports means, SD, CV and p–values for concentration ratios in
controls (first raw of each group, gray background) and patients (second raw,
white) Significant values of the differences are in bold characters. From [186].
3.2 ppm, includes, as known, other choline–containing compounds as
phosphorylcholine and glycerophosphorylcholine. Besides, at short TEs,
this spectral area is further complicated by overlapping contributions
from phosphorylethanolamine and taurine. This uncertainty in the me-
tabolites contributing to the signal gives some ambiguity to the bio-
chemical interpretation of the alterations observed in the choline peak.
Changes in concentration are generally indicative of alterations in mem-
brane composition. Our results suggest that subjects suffering from
migraine feature alterations in the concentrations of myo–inositol and
choline peaks. Further studies are in process in order to achieve a better
biochemical interpretation of these findings.
The objective of our investigation was to allow, by means of an ap-
propriate quantification procedure, the spectral evaluation of those me-
tabolites visible in spectra acquired at short TE, where the complex
spectral pattern and the severe overlap of resonances further compli-
cate the low SNR experimental conditions commonly available in clini-
cal practice. Specifically, an advanced fitting time-domain approach was
applied to the evaluation of the metabolic changes in the cerebellum of
patients suffering from a particular form of migraine during the interictal
period. The quantitative evaluation was based on a library of reference
spectra obtained from model metabolite aqueous solutions of known con-
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centration built up on purpose and investigated under identical experi-
mental conditions. Our results indicate that patients under examination
feature significant changes in some metabolite ratios of clinical interest.
Actually, choline and myo–inositol levels, considered normalized both
to NAA and Cr, statistically decrease in patients with respect to the
corresponding ratios analyzed in normal subjects.
CHAPTER 4
The Brain Metabolism
The metabolic events underlying neuronal activity are still object of in-
tense debate, in spite of the considerable amount of information provided
by neuroimaging techniques, like PET and fMRI. This issue was raised
up by Fox et al. [4, 5], who observed a focal, stationary uncoupling be-
tween CMRO2 , that increases of about 5% during stimulation, CMRGlc
(variation under stimulation: +30 ÷ 50%) and CBF (variation under
stimulation: +30 ÷ 50%). To explain their finding, obtained with PET
during prolonged stimulation, the authors suggested the presence of a
transient anaerobic glycolysis in neuronal energetic metabolism during
functional activation.
Further studies by Pellerin and Magistretti [7] proposed that astro-
cytes had a pivotal role in neuronal metabolism, by conveying lactate
to neurons through an Astrocyte–Neuron Lactate Shuttle. This model
hypothesized that the action potential stimulated the anaerobic glycoly-
sis in neighboring astrocytes, producing lactate; this was then conveyed
from astrocytes to neurons and converted into pyruvate entering the
Krebs cycle to produce the chemical energy needed for neuronal activ-
ity.
4.1 Glucose consumption
While several evaluations of cerebral glucose consumption at rest are
available, on both humans and animals (e.g. see [189–191]), a relatively
low number of studies have been able to assess the variation of this key
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parameter under stimulation. Some studies reported a generic decrease
of cerebral glucose amount during activation, but did not assess the cor-
responding variation of CMRGlc [192]; on the other hand, studies on
freely moving rats reported a constant level [193] or even an increase
of extracellular glucose during stimulation [194]. For a summary of the
functional estimations of CMRGlc changes in human subjects, see Ta-
ble 2.1 at page 37.
The issue of neuronal activation metabolism was raised by the funda-
mental result obtained with PET strategy by Fox et al. [4, 5], regarding
a focal mismatch between the variations of CMRO2 (+5%), CMRGlc
(+30÷ 50%) and CBF (+30÷ 50%) during prolonged, stationary neu-
ronal activity (prolonged stimulation). This stationary phenomenon was
called uncoupling and, according to the authors, it was the manifestation
of a non–aerobic metabolism.
On the opinion of the authors, the exceeding consumption of glucose
can follow two pathways:
• it can be utilized in lactic fermentation;
• it can be utilized for glycogen synthesis.
Both these hypotheses imply that the increase of energy due to activa-
tion is really low1, as the maximum increase of ATP production, arising
from the aerobic2 glucose consumption allowed by the small increase of
CMRO2 and glycolytic consumption of the remaining glucose, was only
+8% above the resting value. This evaluation contrasts with the esti-
mates of energetic requests during activation (for a detailed calculation
see Section 4.3 at page 73).
In order to explain this contradiction, the authors hypothesizes that
the aerobic enzymatic pool is already saturated in resting state, and so
any further energetic requirement must be satisfied anaerobically.
A drawback of these experiments is the very long stimulation uti-
lized: in [4] the tactile stimulation lasts up to 40 min. During this inter-
val, a poor correlation between regions showing variations of CBF and
1The first pathway produces a small amount of Adenosine TriPhosphate (ATP),
the second even requires energy.
2In the literature on brain energetic there is some confusion about the use of
the word ‘aerobic’. This term is often utilized to indicate that a particular process
(anaerobic per se) occurs in presence of oxygen. For instance, Pierre Magistretti in its
papers always calls ‘aerobic glycolysis’ the astrocytic glycolysis. To avoid confusion,
in this Thesis the word ‘aerobic’ is always used to strictly characterize a chemical
process that consumes free oxygen.
Brain metabolism 67
regions showing variations of CMRO2 is observed, while in resting con-
ditions the basal perfusion is colocalized with the oxygen consumption.
As a consequence, the OEF is reduced both in the whole brain and in
the activated region (as identified by CBF measures).
In a further study [5] similar results about the uncoupling between
∆CBF and ∆CMRO2 are reported, in an experiment with visual stimula-
tion; furthermore, a large focal increase of CMRGlc is observed (+51%).
Unlike the small increase of CMRO2 , the increase of CMRGlc is essen-
tially colocalized with the increase of CBF. The molar ratio for the
increase of CMRO2 and CMRGlc is 0.4 : 1 (being 4.1 : 1 the ratio in rest-
ing conditions). Consequently, 91% of the functional increase of CMRGlc
undergo non–aerobic metabolism.
A subsequent study by Ribeiro et al. [112] essentially confirmed these
results, but reported a lower increase of CMRGlc, while Madsen et al.
[114] obtained by Kety–Schmidt technique a really low estimation of
CMRGlc increase (+12%), and no CMRO2 variation.
The 1H–MRSmethod can support interesting experimental evidences
on the metabolic issue raised up by Fox et al. [4, 5], since it is a valid
tool for investigating the metabolic contents of tissues. By means of
such approach, a biphasic time course of glucose concentration during
about 30 min of photic stimulation was observed by Chen et al. [110],
who observed an initial decrease of glucose followed by a slow increase
towards the baseline. They utilized a simple Michaelis–Menten kinet-
ics to obtain the variation of CMRGlc, that was estimated to increase
by 22% during stimulation. This procedure relied on the assumption of
constant transport parameters and constant increase of glucose during
stimulation, and only the waning trend was fitted. The latter increase of
glucose concentration was related to a decrease of energy requirements
due to adaptive phenomena, or to a slight enhancement of the aerobic
pathway, leading to equal ATP production with lower glucose consump-
tion. In both cases this datum qualitatively agreed with the observed
fall in lactate concentration in the later stages of stimulation (see below
for details). By means of 1H–MRS, Frahm et al. confirmed a decrease
in cerebral glucose amount due to stimulation increase [10, 115], and
evaluated a 21% increase of CMRGlc on the basis of the same kinetic
hypothesis adopted by Chen et al. [110]. Finally, Blomqvist et al. [113]
utilized two radioactive analogues of glucose to assess during activation
the increase of total CMRGlc and the increase of the CMRGlc relevant to
an enhancement of the aerobic metabolism. A total increase of CMRGlc
about double of the aerobic increase was found, thus suggesting that
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aerobic and anaerobic pathways are enhanced by activation in similar
degrees.
The variability of the above estimations of glucose consumption is
mainly due to the marked experimental complexity and to the ambiguity
of the measurements. As already underlined in Section 2.2 at page 36,
the PET measures rely on low signals and on several simplifying as-
sumptions, and can be affected by systematic errors due to incomplete
trapping of radiotracers [195]. On the other hand, the 1H–MRS studies
must evaluate the glucose consumption on the basis of dynamic concen-
tration data, and the results are therefore strictly related to the adopted
kinetic model. Both PET and 1H–MRS can evaluate only stationary val-
ues of CMRGlc.
4.2 Lactate role
MRS has been widely used in the most recent literature also to mea-
sure lactate concentration in the brain of humans and animals during
activation (see Table 4.1 for a summary of the data obtained in humans).
Stationary increases of lactate concentration are often related to
pathologies which enhance the anaerobic pathway, due to a paroxysmal
increase in energetic requests as occurs for example in epileptic seizures
[200], or due to an inadequate oxygen delivery compared with the tissue
demand as occurs in ischemia, hypoxia, tumoral tissues.
On the other hand, a transient lactate increase during neuronal acti-
vation has been reported by several studies. The first observation of this
kind was reported in 1991 by Prichard et al. [8]. The authors detected
a maximum variation of about +60% in the primary visual cortex of
the human brain during the first minutes of stimulation, which lasted
for 48 minutes. The intersubject average value of the maximum increase
in lactate concentration during a 12 min stimulation was 54% of the
resting value (the data spanned in the range of about +30 ÷ 90%). In
several subjects the maximum increase of lactate was observed in the
first minutes of stimulation, followed by a slow decline toward the base-
line during and after the stimulation. The temporal resolution obtained
was 6÷ 8 min.
Similar observations were done by Sappey–Marinier et al. [9], who
measured the lactate concentration in the primary and associative visual
cortex during two visual stimulations of 38.4 and 12.8 minutes, spaced
by a 12.8 minutes dark period. The maximum lactate increase coming
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Table 4.1: 1H–MRS measurements of lactate variations in activated re-
gions of human brain.
Ref. Stimulation Stimulation length Subjects Lactate variation
[8] photic 12 min 5 +54%
[8] photic 48 min 1 ≃ +60%
[9] photic 38.4 min 6 +150%
[192] photic 6.5 min (?) 48 ∗
[196] § photic 3 min 7 +92%
[196] § photic 6 min 4 +76%
[197] § auditory 30÷ 60 min 6 †
[198] motor task 6.5 min 7 ‡
[10, 115] photic 4÷ 6 min 25 +68%
[199] § photic 40 s 1 +24%
[11] photic 1 s 5 ≃ −50%
Lactate variations are expressed as percentage of the rest level. The greatest
absolute value reached during or after the stimulation is reported. ∗: no signif-
icant variation observed. †: increase ‡: considerable increase. Also preliminary
results published only in abstract form are reported; they are marked with §
near the reference. From [128].
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from the intersubject study was +150% of the basal level, reached dur-
ing the first minutes of the first stimulation (the temporal resolution
was 6.4 min). The authors obtained also PhosphoCreatine (PCr) and
Inorganic Phosphate (Pi) measurements by means of
31P MRS and in
slightly different experimental conditions; during the first 12.8 min of
stimulation was observed a significant decrease of the [PCr]/[Pi] ratio;
also the evoked potential amplitude, measured in the same conditions,
decreased significantly.
The increase of lactate observed by Prichard et al. [8] and by Sappey–
Marinier et al. [9] could be related to a transient phase of physiological
anaerobic metabolism [4, 5]. However, as remarked by Prichard et al.
[8], the estimate of absolute lactate increase could account only for few
minutes of lactate production at the rate computable from Fox’s studies
[4, 5]. As a consequence, these data suggested that the mismatch be-
tween oxygen and glucose consumption must be restricted to the early
minutes of stimulation. This calculation, nevertheless, relies on the quite
arbitrary hypothesis of a constant lactate transport. The latter decrease
of lactate has been interpreted by Sappey–Marinier et al. [9] as an indi-
cation of a subsequent phase of adaptive response, which could be also
the cause of the decline observed in the evoked potential. This hypoth-
esis implied that the decrease of lactate was not related with a dynamic
recoupling of hemodynamic parameters due to a switch towards the aer-
obic pathway.
The high variability of lactate observed in the intersubject studies
[8, 9, 198] was underlined by Merboldt et al. [192], who did not detect
any significant lactate dynamics in their work, which was conducted on
48 subjects, in correspondence of a wide range of experimental parame-
ters. The observed lactate levels at rest were markedly variable (in the
range of < 0.3 ÷ 1 mM), while the concentration during the prolonged
photic stimulation showed multiples patterns in different subjects. The
great variability of the adopted experimental conditions makes nonethe-
less very puzzling the interpretation of this finding, that disagrees with
several literature data, including some important following works of the
same group [10, 115].
The results described above are not unanimous, probably due to low
lactate concentrations and to different experimental conditions. A fur-
ther confusing effect is the possible lactate binding with proteins, that
strongly influence the spectroscopic visibility of lactate [201]. Anyway,
the main critical point of these studies is the use of prolonged stimu-
lations, that can easily produce complex and partially uncharacterized
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phenomena of habituation or adaptive response. Prolonged photic stim-
ulations, usually employed in lactate experiment, are indeed reported
to be stressful for subjects, thus suggesting to reduce the length of the
experimental sessions [9]. On the other hand it is known that stress-
ing stimulation can generate anomalous lactate response, and a marked
increase in extracellular lactate has been clearly observed with micro-
dialysis on awake, freely moving rats subjected to forms of mild stress
(handling, restraint, tail pinch) [202, 203]. Finally, prolonged stimula-
tions can induce stationary metabolic conditions, where the dynamic
response to transients is possibly missed.
A second question is the poor temporal resolution normally achieved;
the phenomena of neuronal activation span on temporal scales of sev-
eral orders, which in part are still not exactly known: from milliseconds
of electric activity at neuronal level, to several seconds of large scale
vascular events, like variations of CBF and CBV. The metabolic events
probably lie in the middle of this interval, since they are aroused by
the energetic cost of action potential transmission, and, in turn, induce
the vascular response. Measuring the metabolite concentrations with the
same temporal resolution of the hemodynamic events, together with the
use of those stimulations that likely produce a ‘physiological’ activity,
are therefore advisable.
Unfortunately the MRS suffers from a temporal resolution, which is
greatly limited by the poor metabolites SNR, that requires the acqui-
sition of tenths or hundreds of spectra to be averaged. A first partial
solution to such a problem was given by Frahm et al. [10, 115], who
utilized a sliding window averaging to reach a nominal temporal reso-
lution3 of 30 s. The necessary number of spectra was obtained by re-
peating 5 times the paradigm of visual stimulation. In any case, also
this approach requires the use of long stimulations (4 and 6 minutes
stimulations were utilized, with no appreciable differences in lactate ac-
cumulation), and thus it can not obviate the relevant problems. The
observed increase of lactate, +68% of the resting value, was restricted
to the first half of the stimulation, while during the second half the
lactate concentration decreased to basal level. The authors measured
during the same stimulation protocol also the time courses of glucose
concentration and Cerebral Blood Oxygenation (CBO). They observed
a glucose consumption during the whole stimulation, and two peaks of
3Note that, in fact, the moving average approach between subsequent group of
spectra here utilized necessarily induces a smoothing in the measured time–course,
so decreasing the sensitivity to fast changes, as in every case of low–pass filtering.
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blood iper– and ipo–oxygenation, respectively at the beginning and after
the end of the stimulation. In the opinion of the authors, the augment of
glucose consumption can account for the increase of lactate concentra-
tion by hypothesizing 2 min of anaerobic metabolism, in good agreement
with the calculation of Prichard et al. [8] (variations of transport kinet-
ics are ignored also in this estimate); this observation is corroborated by
the measured peak of iper–oxygenation, that lasted just about 2 min.
Upon this set of experimental observations, Frahm et al. hypothesized a
dynamic change in brain metabolism, from anaerobic to aerobic, during
the stimulation: the activation onset could be accompanied by a tran-
sient phase of glycolysis, coupled with the fast CBF changes but not
with the slower beginning of the oxidative phosphorylation. During the
subsequent steady–state phase, hemodynamic and metabolic parameters
could recouple, and the final undershoot of CBO should compensate the
initial anaerobic phase. In this framework, the metabolism as a whole is
entirely aerobic, and the decreases of CBO and lactate during the latter
phases of stimulations are not related to a habituation effect, but rather
depend on a physiological metabolic switch.
This phenomenon was identified with a delay between the astro-
cytic glycolysis and the subsequent neuronal aerobic oxidization of the
produced lactate, according to the ANLS model proposed by Mag-
istretti and Pellerin [7]. This metabolic model provides that astrocytes
have a central role in brain energetic, as neuronal released glutamate
would stimulate astrocytic glycolysis, which in turn produce lactate.
This metabolite would be exported to neurons, that would utilize it as
their main energetic substrate (See Section 4.4 at page 77 for details).
It must be underlined that the interpretation of Frahm’s data [10, 115]
in the context of the ANLS model relies on the hypothesis that the ox-
idative phosphorylation and the lactate diffusion to neurons, that are
events at molecular or cellular level, are slower than regional vascular
events. Nonetheless, during neuronal activation, the molecular events
are required to quickly produce energy, whereas the interpretation sug-
gested by Frahm et al. implies that no energy production occurs during
the 2÷ 3 minutes between the onset of the stimulus and the beginning
of aerobic metabolism. Furthermore, the switch towards aerobic meta-
bolism observed during the steady–state phase occurs very early during
the stimulation, in contrast with the persistent anaerobic metabolism
observed by Fox et al. during prolonged stimulation [4, 5].
In order to further gain in temporal resolution and avoid the ambi-
guities related to prolonged stimulation, we used a time–locked modality
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in an event–related experimental design [11], that involved a MRS in-
tersubject study of lactate concentration in correspondence of a visual
impulsive stimulation. We observed a marked decrease of lactate below
the resting value within 5 s from the end of the stimulation, followed by
a return to the baseline at about 12 s after the end of the stimulation.
Such a result was interpreted as an indication that the neuronal meta-
bolism is aerobic from the onset of neuronal activity. For further details,
see Section 4.5 at page 78.
Furthermore, we proposed an explanation [12] for the increase of
lactate [8, 9, 198] and the uncoupling between CMRO2 and CMRGlc
[4, 5, 112] previously observed during prolonged stimulation, without
involving neither the switch of neuronal metabolism towards anaerobio-
sis [4, 5], neither the nutritional coupling between neurons and glia (see
Section 4.6 at page 84 for further details).
Anyway, further experimental investigations, together with a quanti-
tative analysis of the involved kinetics, are required to effectively link the
early depletion of lactate [11] and the lactate increase observed during
prolonged stimulations [8, 9, 198].
4.3 The cost of brain activity
In order to calculate the energy needs of signaling in the brain, anatomic
and physiologic data can be utilized: in particular they can be used to
analyze the expenditure of excitatory signaling in the grey matter. At-
twell and Laughlin [204] recently reviewed the issue. They analyzed the
transmitter release triggered by a single action potential passing through
a typical neuron of rodent brain. As a simplification, all cells were treated
as glutamatergic, because excitatory neurons outnumber inhibitory cells
by a factor of 9 : 1, and 90% of synapses release glutamate. The energy
needs of all the stages of glutamatergic signaling were estimated by con-
sidering different parameters, such as the number of vesicles of glutamate
released per action potential, the number of postsynaptic receptors ac-
tivated per vesicle released, the ion fluxes and metabolic consequences
of activating a single receptor, and the energy costs of taking up and
recycling glutamate.
The following step was to compare the energy expended on the ef-
fects of glutamate to that needed for the action potential that triggers
glutamate release and for maintenance of the resting potential between
action potentials. By basing their calculations on the passage of signals
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through a single neuron, Attwell and Laughlin [204] obtained a clear pic-
ture of the relative amounts of energy used by different cellular processes
and the relation between energy usage and action potential frequency.
Finally, they multiplied these results by the number of action potentials
occurring in the neurons of a given brain volume to obtain the absolute
energy expenditure.
At rest, a cell with a membrane permeable to Na+ and K+ reaches
an equilibrium with no net charge flux across the membrane, in which
Na+ entry and K+ exit through the membrane conductances exactly bal-
anced by the pumped fluxes in the opposite directions. Action potential
and synaptic signaling involve an influx of Na+, and an equal efflux
of K+ to bring the membrane potential essentially back to its resting
value. The estimates of the ATP consumption by action potential and
synaptic signaling depend on how much extra ATP (above the resting
consumption) is used to reverse these ion movements. To calculate this
it is necessary to take into account the fact that the changes in ion con-
centrations and pump rate, which are evoked by signaling activity, alter
slightly the membrane potential and the resting ion fluxes through the
membrane conductances.
Signaling with one vesicle of glutamate, containing approximately
4000 molecules of glutamate, requires energy to trigger the release of the
vesicle, to power the postsynaptic events activated by the glutamate, and
to recycle the vesicle and its glutamate. The major energy expenditure is
on reversing the ion movements evoked by glutamate’s actions on post-
synaptic N–Methyl–D–Aspartate (NMDA) and non–NMDA ionotropic
receptors, which together require hydrolysis of approximately 1.37 ×
105 ATP molecules/vesicle. The energy usage resulting from activation
of G protein–coupled receptors, including the generation of Ca2+ tran-
sients in spines, is more difficult to predict, but may be approximately
estimated in3000 ATP molecules/vescicle. This metabotropic receptor
consumption is low because of the small volume of a spine and because
the intracellular concentrations of second messengers are low. In total,
the postsynaptic actions of a vesicle of glutamate are powered by the
hydrolysis of 1.4 × 105 ATP molecules. Furthermore, the recycling of 1
vesicle of glutamate uses 11000 ATP molecules, used to take glutamate
up (mainly into astrocytes), convert it to glutamine, export it to neu-
rons, and package it into vesicles. Finally, pumping out the Ca2+ that
triggers the release of the vesicle is estimated to consume 12000 ATP
molecules, and the mechanisms of vesicle exocytosis and endocytosis
may each consume other 400 ATPs, however this mechanism is still in-
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completely understood.
Summing the above mentioned estimates, the energy expended per
vesicle of glutamate released is 1.64× 105 ATP molecules. Postsynaptic
ion fluxes dominate the distribution of energy use (84%). Presynaptic
calcium influx and transmitter recycling are of secondary importance
(7% each); the metabotropic responses of spines and vesicle recycling,
are negligible (2% and 0.5%, respectively). This distribution reflects the
fact that chemical synapses work as an amplifier: approximately 100 ions
enter the postsynaptic terminal for each molecule of glutamate released.
The energetic costs of recycling glutamate and vesicles are low because,
despite the complexity of the mechanisms, the number of molecules in-
volved is small.
Vesicle release is triggered by action potentials, which are produced
by ion movements that must be reversed. From the membrane area
and capacitance that needs to be polarized, 1.15 × 109 Na+ ions are
required to propagate a single action potential through a typical neuron
[204]. Pumping out these ions requires hydrolysis of 3.84 × 108 ATP
molecules. Of this amount, 82% supports action potential propagation
to output synapses along axon collaterals, 14% supports depolarization
of the dendrites, and 4% supports depolarization of the soma.
Averaged over rodent neocortex, each action potential can evoke
glutamate release from approximately 8000 boutons. However, boutons
do not always release a vesicle, and the release probability is dependent
on action potential frequency. At the climbing fiber synapse, the release
probability (at 23◦C) is 0.9 at low stimulus rates, but decreases to 0.15 at
4 Hz (the mean action potential frequency used below). At about 37◦C
in cortical neurons, the average release probability is 0.5 to 0.64 at low
stimulation frequencies, and may be more than halved for frequencies
greater than 5 Hz. As an estimate for an action potential frequency
of 4 Hz at 37◦C, therefore, it can be assumed a release probability of
0.25, so that each action potential will release 2000 vesicles from 8000
boutons. From these results, the energy expended on releasing one vesicle
of glutamate is 1.64 × 105 ATP molecules, so these 2000 vesicles have
an energetic cost of 3.28 × 108 ATP molecules, slightly less than the
cost of the action potential that releases them (3.84× 108 ATP). Thus,
when a neuron fires an action potential, the total ATP consumption is
7.1 × 108 ATP/neuron/spike, most of which is expended on ion fluxes
in axons and at synapses.
From their studies on membrane potentials and input resistances, At-
twell and Laughlin [204] calculated that 3.42×108 and 1.02×108 ATPs/s
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are needed to maintain the resting potential of a typical neuron and glial
cell. In cortical grey matter, there are approximately the same number
of glia as neurons, resulting in a total consumption of 4.44×108 ATPs/s
per neuron (and associated glial cell).
The mean firing rates of neurons in intact animals, engaged in nat-
ural patterns of behavior, are only approximately known. For freely mov-
ing rats, the rates of cortical units range from 0.15 to 16 Hz. The means,
for neuronal populations in different areas and studies, range from 1.5
to 4 Hz. Since these data were obtained in laboratories where sensory
stimuli were controlled and limited, they took the higher value of mean
rate, 4 Hz. Thus, for rodents, the ATP usage on signaling by action po-
tentials and glutamate will be 4(3.84 × 108 + 3.28 × 108) = 2.85 × 109
ATPs/neuron/s. Adding the consumption on the resting potential gives
a total rate of 3.29× 109 ATPs/neuron/s at 4 Hz mean action potential
frequency.
Therefore, 3.42 × 108 ATPs/s are used to maintain the resting po-
tential of a neuron, 1.02× 108 ATPs/s are used to maintain the resting
potential of associated glial cells, 15.4× 108 ATPs/s are used for action
potential signaling at 4 Hz in the neuron, and 13.0 × 108 ATPs/s are
used for glutamatergic signaling from that neuron. This estimate of en-
ergy usage is broadly confirmed by the distribution of mitochondria in
the brain.
These calculations were made by analyzing data coming from rodent
brain, and an adjustment for comparison with human brain data is re-
quired. Few data are available to calculate the postsynaptic ion fluxes
activated by a glutamatergic vesicle in humans. Action potential–related
energy usage may be increased by a greater axon and dendrite length
for at least some neurons in the larger brain, and by the higher mean
firing frequency (perhaps 9 Hz rather than 4 Hz) in primates; anyway
it would be decreased by the lower vesicle release probability at the
higher frequency. More major changes in the predicted energy budget
of the brain will result from the 3– to 10–fold lower density of neurons
in humans, with an unchanged density of synapses, implying a 3– to
10–fold higher number of synapses/neuron. A 10–fold change will in-
crease the fraction of ATP usage devoted to reversing the postsynaptic
effects of glutamate, but will reduce by 54% the specific prediction for
the percentage of energy expended on other phenomena, like axonal ac-
tion potentials, presynaptic Ca2+ entry, accumulating glutamate into
vesicles, and recycling vesicles. The close spacing of terminals along ax-
ons (5 µm, implying a diffusion time of only 25 ms) will make terminal
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and axonal mitochondria functionally indistinguishable.
A first important attempt in drawing a mathematical model for neu-
ronal activation, including the present knowledge on relevant physiologic
and metabolic events, was recently proposed [205]. This model utilizes
the neuronal sodium inflow as the input of the system, and it estimates
the time course of the main observable parameters (BOLD signal, PCr,
ATP, glucose, lactate). The model includes electrophysiological, metabo-
lic, and hemodynamic aspects of the local response of brain tissue during
activation. By adopting this model, the simulations of an activation last-
ing 6 minutes were shown to quantitatively agree with the experimental
data of Frahm et al. [10, 115] on the maximum absolute variation of glu-
cose and lactate amount, even if the simulated time courses were inac-
curate. In fact, these simulated maximum values were reached only after
the end of the stimulation, unless an ad hoc delay in mitochondrial respi-
ration was introduced. Also a decrease of [PCr]/[Pi] ratio was predicted,
in qualitative agreement with the measures of Sappey–Marinier et al.
[9]. At this stage of the studies, the model has relied on the transport
between only two compartments (capillary and neuron), and has not
accounted neither for a possible compartmentalization of metabolism
in neurons and astrocytes, nor for diffusion phenomena in extracellular
space and in remote tissue regions. Although the effectiveness of this
model remains to be proven, it is a fascinating approach that could de-
velop in a more complex and comprehensive model of brain metabolism
and physiology.
4.4 A Model for the brain energetic: the lactate shuttle
The ANLS model is mainly based on the observation that astrocyte end–
feet surround intraparenchymal microvessels, and then represent the first
cellular barrier for glucose entering the brain; furthermore, some neu-
rotransmitters were shown to stimulate the glycogenolysis in astrocytes
[206], which also possess receptors for a variety of neurotransmitters
[207], in particular glutamate. Moreover, it was demonstrated that the
absorption in astrocytes of some neurotransmitters, in particular of glu-
tamate, stimulates glucose uptake, glycolysis and lactate release in the
extracellular space [7].
More in detail, the ANLS model (Fig. 4.1) hypothesizes that the
glutamate released in the inter–synaptic space, as a consequence of the
action potential propagation, is absorbed by astrocytes together with
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other ions, mainly Na+; the increase of the intracellular Na+ concentra-
tion causes an increase over basal level of the Na+/K+ ATPase activity,
and, thanks to the activity of the glutamine synthetase, the absorbed
glutamate is converted in glutamine which is then released outside the
astrocyte and absorbed by the neuron where it will be reconverted in
glutamate to be reutilized as neurotransmitter. The ATP consumption
by the Glu–Gln cycle and by the Na+/K+ pump activity primes glu-
cose uptake in astrocytes and the beginning of the glycolysis; at the
same time, the glycogenolysis is stimulated, providing further glucose
to the glycolysis. Due to the fact that the Krebs cycle is not stimulated
in astrocytes, the Lactate DeHydrogenase (LDH) converts the excess of
pyruvate in lactate, which then diffuses in the intercellular space and is
absorbed into neurons. Finally, within neurons, LDH oxidizes lactate to
pyruvate, which enters the Krebs cycle to be completely oxidized by the
aerobic metabolism, producing the energy necessary for the neuron.
Also subsequent experimental results have been taken to support the
ANLS model. For example, it was found that the GLUcose Transporter
protein type 1 (GLUT1) is present in astrocytes and in the endothelium
of the Blood–Brain Barrier (BBB) [208]. Another finding was that neu-
rons mainly express the lactate dehydrogenase LDH–1 (more suited to
oxidize lactate) while astrocytes mainly express the form LDH–5 (more
suited to reduce pyruvate) [209]; this fact, according to the authors,
would indicate that lactate is produced in astrocytes and consumed in
neurons.
Furthermore Sibson et al. [15] determined the stoichiometry between
the oxidative Glc metabolism and the glutamate–neurotransmitter cy-
cling in the cortex to be close to 1 : 1; this finding indicates the close
coupling between the neuronal metabolism and the recycling of the glu-
tamine released by astrocytes. Finally, it was proposed by Bliss et al.
[210] that lactate may present some advantages as the substrate of choice
during neuronal activity, since it can be converted to pyruvate in absence
of ATP; this thesis is suggested by the mandatory role of lactate for the
recovery of synaptic activity after acute brain pathologies, like ischemia
[211–213], or traumatic brain injury [214].
4.5 The fast dynamics of lactate
The literature has reported so far only experiments performed upon
prolonged stimulations and with low temporal resolution [8–10]. These
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Figure 4.1: The ANLS model: astrocytes undergo ‘activation’, beginning
glycolysis triggered by neurotransmitters, to feed neurons with lactate,
which then is the main metabolic substrate of neurons during activation.
Direct neuronal uptake of glucose is limited by the unfavorable position of
neurons in relation to capillaries. From [12].
studies, performed in vivo by means of 1H–MRS, showed an increase in
lactate during the first minutes of stimulation. Nonetheless, it is crucial
to investigate the early dynamics of the energetic metabolism, with par-
ticular attention to the variations of lactate concentration, since lactate
can be a suitable indicator of the coupling between oxygen and glucose
consumption. To this purpose, we investigated lactate metabolism with
high temporal resolution in order to single out the underlying metabolic
events. We utilized an event–related single–voxel 1H–MRS, that mea-
sures the time–resolved concentrations of lactate during the first seconds
following a very brief visual stimulus, with a temporal resolution of 1 s.
This method supplies dynamic information that is impossible to obtain
in stationary conditions and avoids the appearance of adaptation and
habituation (generally produced by prolonged stimuli) which could mask
transient metabolic events. However, one should keep in mind that the
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role of lactate can not be completely addressed by this approach alone,
first of all because single-voxel spectroscopy can not directly reveal the
compartmentation of lactate between glia and neurons, and secondly
because it is not possible to discriminate among simultaneous changes
in lactate production, consumption and efflux from the region of interest
by measuring only lactate concentration. Anyway, this acquisition strat-
egy can provide information suitable to be potentially integrated with
the various findings reported in literature in a comprehensive model of
energetic metabolism during neural activation.
4.5.1 Methods
Five normal volunteers (aging 23 ÷ 40 years) were studied on a whole-
body system 1.5 T (Signa Horizon LX, standard birdcage head coil -
General Electric Medical Systems, Milwaukee, WI). Written informed
consent was obtained from all subjects prior to investigation. The vi-
sual stimulation was designed to activate selectively ‘interblob’ regions
of primary visual cortex. These neuronal populations are relatively poor
of cytochrome oxidase with respect to the neighboring ‘blob’ regions
[215]. Under these conditions the detection of lactate should be favored.
The ‘interblob stimulation’ consisted of an achromatic square grid of
white/black stripes (angular frequency = 6 cycle/ ◦, duty cycle = 50%,
eccentricity = 5 ◦, brightness contrast white/black = 100%) with a cen-
tral fixation point, on a grey background set at the average brightness of
the grid. The projection device was synchronized with the NMR scanner.
In order to obtain the requested temporal resolution during the first
seconds following the stimulation, we acquired the spectra in a time-
locked modality (Fig. 4.2). This method consists of the presentation
of 1 s visual stimulus, followed by a single acquisition after a fixed Ac-
quisition Delay (AD); The time course is investigated by varying the AD
in separate sessions. ADs of 0 s, 3 s, 5 s, 8 s and 12 s were utilized. within
each session the spectrum was obtained by averaging 128 acquisitions.
The rest condition consisted of a uniformly grey image with a central
fixation point, asking the volunteer to keep the eyes open. The selection
of the VOI, measuring 20 × 30 × 20 mm3(12 cm3) and centered on the
calcarine fissure, was guided by sagittal SE T1weighted scans. Proton
Nuclear Magnetic Resonance (1H–NMR) single voxel spectra were ac-
quired by using PRESS sequence in fully relaxed conditions (TR ranging
between 7500 ms and 15000 ms depending on AD used, TE = 270 ms).
Of course, this approach implies that the Inter–Stimuli Interval (ISI)
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is equal to the TR. The shorter ISI utilized should be longer that the
expected extension of the time–course, to avoid that consecutive spectra
measure the metabolic effect of several precedent stimulation, while it is
required that each spectrum represents only the metabolic state at AD
seconds from the stimulus.
time
×
number
ofscans
Stimulation Acquisition Stimulation Acquisition
TR
AD AD
ISI
Figure 4.2: Schematic of the time-locked experimental strategy: each
spectrum to be averaged is acquired after an Acquisition Delay (AD) from
the presentation of a visual stimulus lasting 1 s. Varying the AD it is
possible to obtain a lactate time–course during the early moments fol-
lowing a stimulation with high temporal resolution. With this design, the
Inter–Stimuli Interval (ISI) is equal to the TR, being the same interval,
translated of AD. From [11].
To quantitatively estimate the lactate variations we developed and
used an automatic Matlab routine [169] that allows the choice of the
baseline and the extremes of integration best suitable for each spectrum.
The distribution of lactate and creatine concentration corresponding to
each AD was evaluated, and its significance was assessed by ANaly-
sis Of VAriance (ANOVA). Then, if the ANOVA suggested the pres-
ence of a dynamics in the metabolite time course, the Least Significant
Difference (LSD) and Scheffe post hoc tests were used to closely identify
the values statistically different from each other. Equality of variances
was verified with Levene’s test, while normal distribution of data was
visually checked with normal Q-Q plot. The null hypothesis was rejected
at 0.01 probability level.
4.5.2 Results
Examples of the spectra obtained on the same subject during rest and
after AD of 0 s, 3 s, 5 s, 8 s and 12 s from stimulus presentation are
shown in Fig. 4.3, while in Fig. 4.4 we report the intersubject time–
course of the lactate variations. These variations are expressed as per-
centage of the rest level of each individual, in order to remove the large
intersubject variability (observed in the range of 100%) of the basal lac-
tate concentration already reported in the literature [192]. As a control
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reference we used the creatine peak, which in fact does not exhibit any
significant variations at different delays (ANOVA: p > 0.57). Within the
time–range investigated, the lactate concentration exhibits an apprecia-
ble decrease at 5 s and 8 s after stimulation (ANOVA: p < 0.005 and
p < 0.008 respectively, LSD post hoc test). The points corresponding
to a delay of 0 s, 3 s, 12 s, are not statistically different from the rest
condition. Instead, utilizing a more conservative post hoc test, like the
Scheffe test, only the point at 5 s appears significantly different; this
fact leads to suppose that 8 s after activation lactate concentration is
returning to the basal level. Anyway, our results indicate that the lactate
level is surely normalized at 12 s [11].
Lactatepeak
1.52.0 0.51.0
ppm ppm
1.52.0 0.51.0
ppm ppm
1.52.0 0.51.0 1.52.0 0.51.0
3 s 5 s
rest 0 s
12 s8 s
1.52.0 0.51.0
ppm ppm
1.52.0 0.51.0
Figure 4.3: Examples of the 1H–NMR spectra obtained in correspondence
of rest, and AD of 0 s, 3 s, 5 s, 8 s and 12 s. The lactate peak is marked
by an arrow. From [11].
Our findings show a decrease in lactate concentration during the
early phase of neural activation. This finding is apparently in contrasts
with the increase observed by others during prolonged stimulations [8–
10], and suggests that the onset of neural activity is accompanied by
lactate consumption. As a further inference, our result is consistent with
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Figure 4.4: Intersubject time–course of lactate percentage variations with
respect to the basal level of each individual, after the presentation of a 1 s
visual stimulus. The data reported are mean±SD. The values which are
significantly different from control are indicated with an asterisk (ANOVA
and LSD post hoc test: p<0.01). From [11].
an aerobic behavior of neurons from the early stage of their activation.
Our result diverges from the ANLS model, since this model should imply
an initial lactate overproduction, rather than a lactate decrease, because
of a transient uncoupling between astrocytic glycolysis and neuronal
oxidation [216].
However, without having quantitative information about the kinetic
of lactate production, consumption and transport between neurons and
glia, we cannot rule out an intrinsic latency in the start–up of the ANLS;
in that case, an initial lactate decrease, followed by an increase over the
basal concentration, could be produced. Nevertheless, our data exclude
an increase in the lactate amount within 12 s after a brief stimulation,
and it is unlikely that further metabolic dynamics could extend after the
observed recovery of baseline, given the experimental conditions adopted
here (impulsive stimulation). Several findings from other groups chal-
lenge the validity of the ANLS model, which is still not supported by
definitive experimental evidence [217]. It is the case, for instance, of
the presence of highly–specific channels for glucose in neurons [218], the
absence of astrocytic metabolic response to increased concentration of
neuronal activity indicators such as K+ [219], and the absence of spe-
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cific mechanisms able to ensure lactate transport to neurons without
dispersion or leakage [220]. Moreover, the findings of Gjedde and Mar-
rett [221] suggest that, during prolonged stimulations, neurons utilize
pyruvate generated directly by neuronal, rather than astrocytic, glycol-
ysis.
Without involving the nutritional coupling between neurons and glia,
the lactate depletion we observed could be explained by a transient hy-
poglycaemia which is likely to happen locally due to the physiological
delay in the hemodynamic response to activation. In fact, a regional
blood flow increase is reported by the perfusion–based event–related
studies just around 5 seconds [222], which correspond to the minimum
we observed in lactate concentration. The direct measure of CMRGlc
could investigate the hypothesis of a transient condition of hypogly-
caemia, but MRS cannot produce this information with temporal res-
olution high enough to match the results we obtained for lactate. The
early use of lactate could have the purpose of replacing glucose when
glucose is not available in sufficient amount (i.e. during the first 5 sec-
onds); but, once flow has increased, neurons could use again glucose as
the main metabolic substrate. In this way, neuronal energetics would
simply change substrate during brain activity due to the changing en-
vironmental conditions, without requiring to fulfil all the hypotheses of
the ANLS model.
4.6 An intriguing hypothesis: the ‘superaerobic’ brain
Several conceptual and experimental evidences suggest reformulating
the energetic role of lactate and the nutritional coupling between neu-
rons and glia. Some of these motivations are described by Dienel and
Hertz [195], who emphasized the ambiguity of the large lactate release
observed in cells cultures [7], the likely presence in astrocytes of glucose
oxidative metabolism during activation, and the slowness of the rates of
metabolism–driven lactate uptake both in astrocytes and neurons. Other
motivations are discussed in the works of Chih et al. [217, 223], who,
for example, criticized the use of α–cyano–4–hydroxycinnamate (4-CIN)
to inhibit the plasmalemmal lactate transport and the use of neona-
tal cortical cells in in–vitro experiments to evaluate the role of lactate.
Moreover, these authors underlined two crucial facts: the first is that
the LDH–1/LDH–5 expression respectively in neurons/astrocytes does
not imply at all that lactate is produced in astrocyte and consumed in
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neurons; the second is that the participation of astrocytic end–feet to
the BBB could not be sufficient to demonstrate a preferential uptake
of glucose by astrocytes, since neurons have highly–specific channels for
glucose – the channel GLUcose Transporter protein type 3 (GLUT3) –
which are much more efficient and faster than those of the astrocytes
[218].
Other findings, some of them here reported, challenge the validity of
the ANLS model:
• the absence of astrocytic metabolic response to increased concen-
tration of neuronal activity indicators such as K+ [219];
• the evidence that, during prolonged stimulations, neurons utilize
pyruvate generated directly by neuronal rather than astrocytic
glycolysis [221];
• the model, proposed as a general metabolic pathway, has some
experimental evidence only for glutamatergic neurons. No evidence
is available to support the existence of an astrocytic response to
activity of other classes of neurons (for instance, GABAergic);
• the evidence that lactate concentration decreases in the early phase
after stimulation [11], while the ANLS model should imply an
initial lactate overproduction, because of a transient uncoupling
between astrocytic glycolysis and neuronal oxidation.
.
We would like to focus the attention on the following points.
The absence of a specific transport for lactate
Even if the presence of MonoCarboxylic acid Transporter protein type
1 (MCT1) on astrocytes and of MonoCarboxylic acid Transporter pro-
tein type 2 (MCT2) on neurons was considered to support the ANLS
model [220] Actually, the absence of a specific mechanism able to en-
sure lactate transport to neurons without dispersion or leakage it is
quite surprising. Lactate transport is passively governed by concentra-
tion gradients trough these generic channels, and this is strange if we
accept that astrocytic lactate is the mandatory substrate for neurons,
as the involved kinetics appears slow and inefficient.
The unresolved question of the ‘uncoupling’
Even if the ANLS hypothesis was suggested to imply the reported mis-
match between CMRGlc and CMRO2 [10, 211, 212], actually, this de-
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duction is quite debatable, because, if the glycolysis in the astrocytes
is aimed at producing lactate to be forwarded to neurons and used in
the Krebs cycle, then the process as a whole is aerobic, and glucose
catabolism is coupled to oxygen consumption. At the most, the ANLS
model could predict an increase in CMRGlc without a concomitant in-
crease in CMRO2 only in the early stage of activation, but of course this
transient phase reasonably extends in a temporal range of seconds, and
not of minutes as hypothesized by Frahm et al. [10]. Only a leakage of
astrocytic lactate could account for the well–known mismatch between
CMRGlc and CMRO2 [4, 5].
It is advisable to stress that the uncoupling observed by Fox et al.
[4, 5] is a stationary mismatch between glucose and oxygen consump-
tion increases during neuronal activity. It is well known that, in resting
conditions, the brain energetics is entirely aerobic, with a stoichiometric
coupling between glucose and oxygen consumption4 [50]. Fox et al. mea-
sured in the visual cortex [5] a resting consumption of oxygen and glucose
of 1.71±0.18 µmol min−1100 g−1 and 0.42±0.03 µmol min−1100 g−1 re-
spectively, with a resting–state molar ratio of 4.1 : 15. The visual stimu-
lation induced a 51% increase of CMRGlc, up to 0.63 µmol min
−1100 g−1,
and only a 5% increase of CMRO2 (up to 1.79 µmol min
−1100 g−1). Con-
sequently, the molar ratio between ∆CMRO2 and ∆CMRGlc was only
0.4 : 1 and this stationary mismatch between metabolic substrates in-
creases led to a ratio CMRO2/CMRGlc near 2.8 : 1.
The doubtful advantage of using lactate instead of glucose
Even if lactate was proposed to have some advantages during neuronal
activation since it can be converted to pyruvate in absence of ATP [210],
actually, in this latter case, lactate should be however produced at the
expense of an initial consumption of ATP in astrocytes, then, the ener-
getic convenience is not evident at all, unless neurons had a large basal
reserve of lactate. But the basal concentration of lactate is low in human
4The complete reaction for glucose aerobic oxidization via glycolysis, Krebs cycle
and respiratory chain is:
Glc + 36ADP + 36Pi + 36H
+ + 6O2 ⇀ 6CO2 + 36ATP + 42H2O.
5This value is somewhat less than the canonical value of 6 : 1. Anyway, PET mea-
surements suffer from several possible systematic effects and are model–dependent.
In this context, the essential fact is the remarkable variation between resting and
activated molar ratios, measured in the same experimental conditions.
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brain, 0.5 ÷ 1 mM [168], and a local accumulation of lactate must be
avoided not to alter the intracellular redox state.
It is important to note that lactate is preferentially used instead of
glucose only when lactate is present in high amounts, as shown just by
Bliss et al. [210]. Nevertheless, while accumulation of lactate is a known
effect of acute brain pathologies (so the consumption of lactate during
the recovery phase could also have the purpose of cleaning the environ-
ment from this ‘waste’ damage product), it unlikely occurs during neu-
ronal activation, since brain lactate concentration increases slightly dur-
ing physiological stimulations [8]. Moreover, recent findings have shown
that lactate can support only some neuronal functions within some neu-
ronal populations [217], and that among the supported functions a nor-
mal synaptic activity is not guaranteed [224].
A different hypothesis about the roles of lactate and astrocytes
In our opinion, astrocytes do undergo metabolic activation by begin-
ning glycolysis triggered by neurotransmitters, as stated in the ANLS
model as well, but only in order to support the Glu–Gln cycle [15],
which removes neurotransmitters from the intersynaptic space in order
to avoid a saturation of the stimulation. Beside this ‘cleaning’ function,
glia could certainly have other functional tasks, for example it has been
recently proposed that they could be intimately involved in brain in-
formation processing [225]. However, a major nutritional role for them
does not seem to be acceptable, since this hypothesis implies too many
ambiguities, as largely above discussed.
Of course, it is reasonable that part of lactate produced in astrocytes,
as a consequence of glycolysis, is conveyed to neurons; anyway, here
it would be metabolized together with the main neuronal metabolic
substrate, which is the glucose directly uptaken trough the high specific
receptors GLUT3 (Fig. 4.5). In this way, the neuronal consumption of
lactate would have the twofold meaning of reducing the excess of lactate
and coping with the energetic demand if needed, without necessarily
being the final aim of astrocytic activation.
Supporting this interpretation, we observed a lactate decrease un-
der its rest level in the first seconds following an impulsive stimulation
[11]. This result suggests that the lactate consumed in this stage is not
provided entirely by astrocytes. Indeed, lactate appears to be equally
accumulated in neurons and astrocytes [195]. Moreover, the early lac-
tate consumption can be explained by a transient hypoglycaemia which
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is likely to happen locally due to the physiological delay in the hemody-
namic response to activation. In fact, a regional blood flow increase is
reported by the perfusion–based event-related studies just around 5 sec-
onds [222], which correspond to the minimum observed in lactate concen-
tration [11]. Then, the use of lactate would have the purpose of replacing
glucose when glucose is not available in sufficient amount (i.e. during the
first 5 seconds), while, once the flow has increased, it is reasonable that
neurons use again glucose as their principal metabolic substrate. In other
words, neuronal energetics would change substrate during brain activity
due to the changing environmental conditions, and would not require
the hypothesis of a specialized mechanism to feed neurons.
By accepting this more traditional picture of neuronal energetics,
the several ambiguities previously described are consequently solved. In
particular, the absence of an efficient mechanism for lactate transport
is not surprising if astrocytes are not required to feed neurons. Further-
more, the uncoupling between CMRGlc and CMRO2 can be accounted
for. Indeed, when lactate concentration increases due to the activation
of astrocytes, lactate diffuses through the generic channels in the inter-
cellular space surrounding astrocytes. Following the gradients of con-
centration, part of this exogenous lactate will go into activated neurons
where it can be oxidized together with glucose, and the remaining will
go into blood vessels [193], or will diffuse towards other brain regions.
Consequently, an amount of glucose consumed by astrocytes to produce
lactate would be subtracted from the utilization in the Krebs cycle and,
thus, would be uncoupled to the oxygen consumption, originating the
previously discussed mismatch, that is a major experimental finding not
accounted by the ANLS model.
Numerous findings present in literature appear not to perfectly fit
into the largely accepted hypothesis of glia feeding neurons with lactate
(ANLS model), at least in its stronger formulation, of obliged and ‘stoi-
chiometric’ coupling between neuronal and astrocytic metabolism [226].
The return to a more traditional description of neuronal energetics, in
which neurons can metabolize directly uptaken glucose to support their
activity, at least during some stage of their activation, allows an easier
‘solution of the puzzle’, where both the points in favor of and the points
contrary to the ANLS model, may find a more appropriate collocation.
Important findings supporting this view were recently reported by
Kasischke et al. [227]. By means of the intrinsic β–Nicotinamide Ade-
nine Dinucleotide (NADH) fluorescence, they observed in hippocampal
slice a spatiotemporal partitioning of glycolytic and aerobic metabolism
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between astrocytes and neurons during stimulation: an early aerobic me-
tabolism confined in neurons is eventually sustained by late activation
of the ANLS. This interpretation is compatible with the initial decrease
of lactate observed by us, as the initial aerobic stage implies the con-
sumption of metabolic substrates (glucose and/or lactate) not produced
by the astrocytes.
According to this model, the transient mitochondrial NADH oxi-
dation is the direct consequence of respiratory chain activation as the
physiological event underlying the macroscopic signs of aerobic metabo-
lism, all of which occur within the first seconds after onset of induced
activity. These results confirm that early neuronal aerobic metabolism is
the default response to increased neural activity. Only after a significant
period (10 s) with possible depletion of substrates for oxidative meta-
bolism (mainly lactate [11, 228]) is the astrocytic glycolysis activated.
Thereby, extracellular lactate might serve as a buffer preventing ac-
tivation of the ANLS during minor or short–lasting neural activity. The
observation that the transient NADH production as an indicator of gly-
colysis in astrocytes exceeds neuronal NADH consumption and further
increases with longer stimulation strengthens this interpretation.
The further (difficult) step is the exact determination of the degree
of activity normally sustained without the ANLS activation. It is possi-
ble that normal, ‘physiological’ activity doesn’t require the intervention
of astrocytes, and that only prolonged activations trigger the lactate
shuttle, just as suggested in our model [11, 12].
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Figure 4.5: Alternative to the ANLS model: astrocytes activate them-
selves, beginning glycolysis triggered by neurotransmitters (B), simply to
support the Glu-Gln cycle, which cleans the intersynaptic space from neu-
rotransmitters. The unfavorable position of neurons in relation to capil-
laries is not limiting for the direct glucose uptake (A), thanks to the high
specific receptors GLUT3 present in neurons. Part of lactate produced in
astrocytes is conveyed to neurons, and used together with the principal
neuronal metabolic substrate, which is the glucose directly uptaken by
neurons. In this way part of lactate can be recycled if needed, leading
to an optimal use of all the available metabolic substrates. The lactate
consumed in the first moments is already reasonably present in neurons
(lactate buffer), in dynamic equilibrium with pyruvate. The shaded regions
emphasize the modifications made to the ANLS model. From [12].
CHAPTER 5
Conclusions
The main aim of the work described in this Thesis was to provide more
detailed and accurate information on the CNS activation. In this frame-
work, a method to obtain high–temporally–resolved MRS spectra and
an adequate spectra quantification method were developed and applied.
Our results on brain metabolism under activation [11, 12] showed
a dynamic decrease and a subsequent increase of lactate in the active
brain, in the few seconds following an impulsive stimulation. These re-
sults are quite interesting and unexpected, as every lactate measurement
in past studies showed a stationary increase of lactate, on temporal scales
of minutes. This finding conducted us to slightly reformulate the ANLS
model, deemphasizing the role of lactate and hypothesizing that cerebral
metabolism switches from purely aerobic to partially anaerobic (due to
astrocytic contribution), while neuronal metabolism remains aerobic in
every phase. This view address both the mismatch between oxygen and
glucose consumption [4], the increase of lactate during long stimulations
[8] and the dynamic decrease observed by us [11].
In a recent, important article [227] an analogue triggering of as-
trocytic glycolysis by neuronal aerobic metabolism was observed with
two–photon fluorescence imaging on an hippocampal slice preparation.
The observation of an early lactate consumption by neurons is giving
a contribution to a further developing of our knowledge of the brain
activity.
Useful information on BOLD contrast and in particular on the influ-
ence of the vascular network structure on its generation can be provided
by the studies on spinal cord functional activity. Obviously, further in-
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vestigations are required to identify the experimental conditions more
suitable to reliably obtain functional maps of the spinal cord activation,
and to assess the specificity of the observed signal and its relationships
with the underlying neuronal activity. However, spinal cord fMRI in
healthy and injured subjects would probably become a valuable clin-
ical and scientific tool for the non–invasive assessment of spinal cord
function.
The contributions of several Nuclear Magnetic Resonance techniques
to the knowledge of the CNS are important, and would bring to fur-
ther increase with the integration of different modalities, like PET and
Electro–EncephaloGraphy (EEG), in the same experimental session.
This integration is predicted to greatly increase the obtainable data,
compensating the weaknesses of each technique, with the integration of
complimentary information.
Nonetheless, a key feature for a further development of our knowl-
edge of the human brain by Nuclear Magnetic Resonance techniques
is the availability of ultra–high field magnets (7 T and above). They
have been used in human research only recently. The results published
so far indicate that significant improvements can be obtained in many
applications in the fields of MR imaging (functional and anatomic) and
spectroscopy (of proton and of low–γ nuclei) [31].
During the last decade an increasing amount of experimental data
on brain function has been produced. A clear vision of how the human
brain works is still not possible, and the research on the higher mental
functions is just at the beginning. However it is evident that the unpaired
ability of NMR to obtain information on the brain in a non–invasive way,
and the continuous developing of new NMR–based techniques, give us
an incredible cognitive power. The correct and full exploitation of this
power lies with us.
APPENDIX A
An outlook on an alternative fMRI technique:
perfusion imaging
Functional techniques of neuroimaging based on a metabolic-vascular
approach, such as fMRI or PET, reveal neuronal activation in terms of
an increase in measured signal during the execution of a task, when com-
pared to a control state, with lower or different functional involvement.
This response reflects the task–induced switch between two different
levels of neuronal activity [1].
Areas showing a significant decrease of the signal have also been
observed during functional fMRI and PET experiments [229–233]. Were
the relationship linking neuronal firing, local metabolism and circulation
hold true also for decreased synaptic activity, then the signal decrease
could well be regarded as related to neuronal deactivation [230]. With
this in mind, the investigation of signal decreases proves quite intrigu-
ing, especially given that many decreases appear to be largely task–
independent [230]. This fact supports the idea of an organized mode of
brain function that is present as a baseline or default state, and suggests
a modern approach to functional studies. One example of this is that
suggestive deactivations of the limbic and paralimbic structures have
recently been observed during cognitive tasks [233], and have been as-
cribed to an inhibition of emotional activity in order to improve the
performance during on–going higher cognitive processing.
Several possible scenarios are compatible with the presence of task–
related signal decreases, and the investigation of the physiological origins
of such phenomena, together with the definition of the intrinsic meaning
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of ‘neuronal deactivation’, has become an issue of debate. A reduced
neural activity, when intended as a drop in the neural firing, can in fact
result either from decreased neural input, or from an increase in synaptic
inhibition due to local GABA release. The former case is associated with
decreased glucose consumption and CBF, whereas the latter one causes
a rise in energy demands and CBF.
Metabolic–vascular approaches can thus reveal the cortical regions
where the afferent function decreases, but they are not capable of distin-
guishing between the zones of inhibition and those of excitation [2]. The
fact that the afferent function, and not the neuronal spiking, determines
all properties of the functional hemodynamic signals has widely been
demonstrated by Logothetis et al. [1] and by Lauritzen [2]. The con-
clusion drawn from these observations is that, in this context, neuronal
deactivation merely refers to a decreased input to a brain region.
As regards the physiological genesis of signal decreases, Harel et al.
[234] suggested caution when interpreting the negative signals as de-
activations, given that a simple hemodynamic effect, consisting of the
so–called vascular steal, can also generate such phenomena. They indeed
observed a reduction of both the BOLD signal and cerebral blood volume
in higher–order visual areas of the anaesthetized cat in response to full–
field drifting gratings, whereas such regions are known to increase their
neural activity during the task used. Somewhat similar experiments were
conducted on conscious humans at 7 T by Shmuel et al. [235]. Follow-
ing a partial visual field stimulation, some areas in the medial occipital
cortex, strictly adjacent to the activated regions of the primary visual
cortex, exhibited a drop in both the BOLD signal and cerebral blood
flow. Given the stimulation used, the authors excluded an increase of
neural activity in such areas; on the contrary, they showed that a reduc-
tion of the oxygen consumption rate can be deduced by applying Hoge’s
model [124], thus inferring that the observed phenomenon originated
from a decreased neural activity (albeit that a contextual intervention
of a pure hemodynamic effect was not excluded). Most importantly, neu-
ronal deactivation, as emphasized by Gusnard et al. [236], seems to be
the most suitable mechanism whenever the signal decreases are located
in spatial positions which are remote from the regions where the positive
signal changes take place, as the premise of a vascular steal would only
be applicable to areas strictly adjacent to the activated tissue, at least
in physiological conditions.
Such considerations imply ambiguity in interpreting signal decreases.
As a first step of investigation, before inferring deductions about the
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physiology and role of deactivation, we believe that it is essential to ver-
ify if different functional techniques give congruent results. In the studies
conducted by Harel et al. [234] and by Shmuel et al. [235], overlapping
areas exhibiting a drop in BOLD and perfusion signals were shown in
the visual region in correspondence of partial visual stimulation. The de-
termination of whether or not the convergence of perfusion and BOLD
data also holds true in different cortices was the main purpose of our
experiment. To address this question, we focused on a human patho-
logical model of task–related flow reduction, namely an ArterioVenous
Malformation (AVM). It is known that the AVM presence determines
a global redistribution of brain perfusion. Function–related phenomena
of flow steal can be expected in such pathologies, due to an increased
flow in the AVM which subtracts blood flow to other brain areas [237].
The presence of a large AVM thus creates ideal conditions for studying
how decreases in regional blood flow are detected by functional MRI,
and combined BOLD–perfusion experiments can be applied to evaluate
the relative sensitivity of different functional MRI approaches to reduc-
tions in CBF. In particular, we utilized an Arterial Spin Labeling (ASL)
sequence to obtain BOLD maps and perfusion maps in the same exper-
imental session.
Methods
A 30 year–old patient affected by a large AVM of the superior frontal
gyrus of the right hemisphere, associated with an isolated enlargement of
the lateral ventricle of the same hemisphere, was examined on a whole–
body 1.5 T system (GE Signa Horizon LX, standard birdcage head coil).
The patient was neurologically normal, except for a slight impairment
in the movement of the toes of his left foot. Written informed consent,
according to the declaration of Helsinki, was obtained prior to investi-
gation.
In order to evaluate the basal condition of brain blood circulation,
perfusion–weighted images were acquired utilizing the multi–slice Flow–
sensitive Alternating Inversion–Recovery (FAIR) sequence introduced
by Yang et al. [238]. The sequence parameters were: thickness of the
inversion slab = 100 mm, TE = 25 ms, TR = 56 ms, Inversion Time
(TI) = 1.2 s, delay time = 3 s, number of slices = 10, slice thick-
ness = 5 mm, number of repetitions = 100 (50 slice–selective and 50
non–selective inversion recovery images).
The patient was then studied during a simple motor task (finger–
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tapping of the left hand), utilizing the FAIR sequence (delay time= 1.8 s,
the other parameters are described above) in order to obtain perfusion–
based and BOLD–based functional maps. The BOLD maps resulted
from the detection of the BOLD effect, as revealed by the analysis of
the FAIR images acquired in the absence of selective inversion. The
functional stimulation consisted of a block–designed paradigm with 10
task periods of motor stimulation which alternated with 10 periods
of rest. Each period lasted for 10 functional volumes, and each vol-
ume was composed of 10 slices. The original time–series of 200 vol-
umes preliminary underwent a motion–correction procedure based on
the Levenberg-Marquart’s least square fit of two translational and one
rotational parameters. Linear drifts were removed from the time–series,
and a bi–dimensional spatial filter was applied to each image slice us-
ing a 6 mm FWHM gaussian kernel. Two subseries of 100 repetitions
of tagged and non–tagged volumes were subsequently extracted from
the 200 volumes time–series. In order to produce the time–series of
perfusion–weighted images, the two subseries first underwent a scan–
by–scan subtraction. This combination produced the image time–series
which were used in perfusion–based signal change detection. Ordinary
functional time–series, to be used in BOLD contrast mapping, were ob-
tained by considering the partial time–series of non–selectively inverted
volumes. CBF and BOLD activation maps were generated by perform-
ing Student t–test for each voxel between rest and task conditions. Since
BOLD–based and perfusion–based functional maps do not exhibit the
same CNR (with the former being higher than the latter [124]), applying
the same threshold to the correspondent t–score images was not useful
for descriptive purposes. In order to optimize the visual comparison of
the resulting readouts of brain activity, it was assumed that both meth-
ods could reproduce the same positively activated areas in the primary
motor cortex as identified by one of the two methods. Statistical maps of
perfusion responses were generated choosing a threshold correspondent
to p< 0.05, and the threshold for the BOLD maps was then adjusted
to realize the same number of positively activated voxels in the primary
motor cortex of the perfusion maps, which intrinsically possess an higher
degree of specificity [239, 240]. A similar approach was used in the stud-
ies by Luh et al. [239] and by Shmuel et al. [235] to evaluate the different
locations of the same number of activated and, respectively, deactivated
pixels revealed by perfusion and BOLD. Here, since we were interested
in investigating the sensitivity of the two methods to task–related sig-
nal decreases, we decided to fix only the number of positively activated
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pixels in the primary motor cortex. Minimum cluster size was not im-
posed. The red–yellow colors were chosen to represent positive t–score
values (task–related signal increases), while the blue–cyan colors indi-
cated negative t–score values (task–related signal decreases). Functional
maps were finally overlaid to the mean (static) reference image slices.
Results
The perfusion-weighted images acquired in basal condition (Fig. A.1)
reveal a strong flow increase in the superior frontal cortex of the right
hemisphere, corresponding to the nidus of the AVM. Less evident are a
decreased flow in the most posterior right occipito–parietal cortex and a
slight decrease in the dorsal frontal cortex compared with the left (nor-
mal) side. The ventricular enlargement is recognizable as hypointense.
Slice1 Slice 2 Slice 3 Slice 4 Slice 5
Slice 6 Slice 7 Slice 8 Slice 9 Slice 10
Figure A.1: Perfusion–weighted images of the examined patient affected
by an AVM associated with an isolated enlargement of the lateral ventricle
of the same hemisphere. The images were acquired utilizing a multislice
FAIR sequence. From [241].
The perfusion–based and the BOLD–based functional maps obtained
in the present study (Fig. A.2) are basically similar, since both depict the
expected motor activation in the right rolandic cortex. Several marked
difference exist, however, one of which being that in the functional per-
fusion map it is more evident that the activation of the motor cortex
in the right side is accompanied by a decreased CBF in the frontal and
occipito–parietal territories subserved by branches of the anterior, mid-
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dle and posterior cerebral arteries. This evidence can be explained by
the steal phenomena which can be induced by the presence of the AVM.
The perfusion map also shows a more evident activation of the ipsilat-
eral motor cortex, whereas there is no activation in the supplementary
motor region, present in the BOLD map.
t-scoret-score
A:FAIR map B: BOLD map
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Figure A.2: A: Perfusion–based activation map obtained through the
FAIR sequence during a motor activation of the left hand. B: Activa-
tion map obtained by revealing the BOLD effect present in the images
of the FAIR time–series without the selective inversion. Color bar indi-
cates t–score values. Negative t–score values occur for task–related signal
decreases. From [241].
Investigating the sensitivity of BOLD and perfusion MRI to flow–
reductions holds a particular interest. Our results, obtained on a patho-
logical model for flow–reductions, deriving from task–related flow–steal,
show that the ASL technique is capable of detecting the areas where
a task–related CBF decrease occurs as a vascular consequence of the
pathology examined (Fig. A.2 A). On the other hand, the spatial extents
of the regions of decreased perfusion signal differ from what revealed by
BOLD maps (Fig. A.2 B). As the perfusion–based maps must be taken
as a reference in the detection of vascular phenomena, the above finding
indicates that BOLD maps can be susceptible to ambiguities in the de-
tection of reduced flow areas, and, specifically, might underestimate flow
decreases. Given that flow reductions in physiological conditions can be
related to a decreased functional activity [2] (if phenomena of vascular
steal are known not to occur), we further suggest that perfusion func-
tional maps may prove generally more reliable than BOLD maps in the
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localization of deactivated areas.
In principle, the perfusion–based fMRI approach also shows several
advantages over the BOLD–based approach in the detection of deacti-
vated areas. By virtue of its high spatial specificity [239, 240], perfusion–
based fMRI has been proposed as gold standard [242] for functional
imaging. As demonstrated by Lauritzen [2], the degree of perfusion is
highly correlated with the neural input of the system, and flow reduc-
tions are expected in correspondence to deactivation due to decreased
input, although it might occur that large deactivations are represented
by very moderate changes of blood flow [243]. Therefore, whenever flow–
steal phenomena can be excluded by other a–priori knowledge, perfusion
methods enable a plain interpretation of decreased signal in terms of neu-
ronal deactivation, without involving over–reaching hypotheses about a
complex interplay of more metabolic–vascular parameters.
As regards the BOLD contrast, on the other hand, Logothetis et
al. [1] have firmly assessed a linear correlation between neural activity
(specifically, the neural input) and BOLD contrast in the primary visual
cortex of anesthetized monkeys. This finding unambiguously demon-
strates the link between neuronal electric events and metabolic–vascular
phenomena. Despite the above evidence, it should be recalled that BOLD
contrast can suffer from poor spatial specificity, and false activations can
be observed in draining veins, especially for single–condition mapping
[3]. Furthermore, the dynamics of the local metabolic-vascular parame-
ters might result from the interaction of several modulation factors,
which may be typical to each single subject, each single physiologi-
cal condition and each single brain region [98]. BOLD signal decreases
could thus occur (apart from in regions eventually interested by vascular
steal) in activated regions with a modified metabolic–vascular dynamics,
where the consumption rate or the local blood volume would increase
more than blood flow. Such an eventuality would imply the production
of false deactivations.
The detection of deactivated areas gathers the opportunity to greatly
extend our knowledge of brain function, as it permits the in–depth study
of the potential suppression of information processing in regions that
are not engaged in task performance. Nonetheless, the presence of task–
related signal decreases does not necessarily imply deactivation phe-
nomena, and relating measured signals with deactivation phenomena
remains a challenge for scientific research. Although the occurrence of
decreases in CBF was not physiologically related to the activation, but
was rather generated from recognized pathological phenomena, the re-
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sults obtained in the present study encourage an extensive application
of functional perfusion MRI in the study of deactivation.
APPENDIX B
Acronyms
1H–NMR Proton Nuclear Magnetic Resonance
1H–MRS Proton Magnetic Resonance Spectroscopy
13C–MRS Carbon Magnetic Resonance Spectroscopy
4-CIN α–cyano–4–hydroxycinnamate
AD Acquisition Delay
Ala L–alanine
ANLS Astrocyte–Neuron Lactate Shuttle
ANOVA ANalysis Of VAriance
ASL Arterial Spin Labeling
Asp Aspartate
ATP Adenosine TriPhosphate
AVM ArterioVenous Malformation
BBB Blood–Brain Barrier
BOLD Blood–Oxygenation Level–Dependent
CBF Cerebral Blood Flow
CBO Cerebral Blood Oxygenation
CBV Cerebral Blood Volume
CV Coefficient of Variation
Cho Choline
CMRGlc Cerebral Metabolic Rate of Glucose
CMRO2 Cerebral Metabolic Rate of Oxygen
CNR Contrast–to–Noise Ratio
CNS Central Nervous System
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Cr Creatine
CSF Cerebro–Spinal Fluid
CRLB Crame´r–Rao Lower Bounds
dHb deoxyhemoglobin
DSS 2,2–dimethyl–2–silapentane–5–sulfonate
DTI Diffusion Tensor Imaging
EEG Electro–EncephaloGraphy
EPI Echo Planar Imaging
FA Flip Angle
FAIR Flow–sensitive Alternating Inversion–Recovery
FID Free Induction Decay
FLASH Fast Low Angle SHot imaging
fMRI functional Magnetic Resonance Imaging
FOV Field Of View
FSE Fast Spin Echo
FWHM Full–Width Half–Maximum
GE Gradient Echo
GABA γ–AminoButyric Acid
Glc D–glucose
Gln L–glutamine
Glu L–glutamate
GLUT1 GLUcose Transporter protein type 1
GLUT3 GLUcose Transporter protein type 3
Glx sum of L–glutamate and L–glutamine
Gly Glycine
HbO2 oxyhemoglobin
HLSVD Hankel Lanczos Singular Values Decomposition
hrf hemodynamic response function
ISI Inter–Stimuli Interval
Lac Lactate
LDH Lactate DeHydrogenase
LSD Least Significant Difference
MCT1 MonoCarboxylic acid Transporter protein type 1
MCT2 MonoCarboxylic acid Transporter protein type 2
mI Myo–inositol
MM MacroMolecules
MR Magnetic Resonance
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MRI Magnetic Resonance Imaging
MRS Magnetic Resonance Spectroscopy
MWA Migraine With Aura
MWOA Migraine WithOut Aura
NAA N–acetyl–L–aspartate
NAAG N–acetyl–L–aspartylglutamate
NADH β–Nicotinamide Adenine Dinucleotide
NIRS Near InfraRed Spectroscopy
NMDA N–Methyl–D–Aspartate
NMR Nuclear Magnetic Resonance
OEF Oxygen–Extracted Fraction
PCr PhosphoCreatine
PET Positron Emission Tomography
Pi Inorganic Phosphate
PFC PerFluoroCarbon
PRESS Point–RESolved Spectroscopy
Scyllo Scyllo–inositol
SD Standard Deviation
SE Spin Echo
SEEP Signal Enhancement by Extravascular water Protons
SNR Signal–to–Noise Ratio
SSFSE Single Shot Fast Spin Echo
SVD Singular–Value Decomposition
Tau Taurine
TCA TriCarboxylic Acid
TE Echo Time
TI Inversion Time
TR Repetition Time
VOI Volume Of Interest
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APPENDIX C
Publications
Edited books
1) Proceedings of the International School on Magnetic Resonance
and Brain Function, edited by Bruno Maraviglia, Federico Giove,
and John C. Gore, Magnetic Resonance Imaging, Volume 21, Issue
10, Pages 1111-1332 (December 2003).
International papers
1) S. Mangia, F. Giove, M. Bianciardi, F. Di Salle, G. Gar-
reffa, B. Maraviglia. Issues about the construction of a meta-
bolic model for neuronal activation. J. Neurosci. Res., 71:463–467
(2003).
2) S. Mangia, G. Garreffa, M. Bianciardi, F. Giove, F. Di
Salle, B. Maraviglia. The aerobic brain: lactate decrease at
the onset of neural activity. Neuroscience, 118:7–10 (2003).
3) M. A. Macr`ı, G. Garreffa, F. Giove, A. Ambrosini, M.
Guardati, F. Pierelli, J. Schoenen, C. Colonnese, B. Ma-
raviglia. Cerebellar metabolite alterations detected in vivo by
proton MR spectroscopy. Magn. Reson. Imaging, 21:1201–1206
(2003).
4) F. Giove, S. Mangia, M. Bianciardi, G. Garreffa, F. Di
Salle, R. Morrone, B. Maraviglia. The physiology and me-
tabolism of neuronal activation: “in vivo” studies by NMR and
other methods. Magn. Reson. Imaging, 21:1283–1293 (2003).
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5) S. Mangia, F. Di Salle, G. Garreffa, F. Esposito, F.
Giove, S. Cirillo, R. Morrone, B. Maraviglia. Perfusion–
based fMRI in the study of a pathological model for neuronal de-
activation. Brain Res. Bull., 63:1–5 (2004).
6) F. Giove, G. Garreffa, G. Giulietti, S. Mangia, C. Co-
lonnese, B. Maraviglia. Issues about the functional MR Imag-
ing of the human spinal cord. Magn. Reson. Imaging, 22:1505–1516
(2004).
7) M. A. Macr`ı, G. Garreffa, F. Giove, M. Guardati, A.
Ambrosini, C. Colonnese, B. Maraviglia. In vivo quantita-
tive 1H–MRS of cerebellum and evaluation of quantitation repro-
ducibility by simulation of different levels of noise and spectral
resolution. Magn. Reson. Imaging, 22:1385–1393 (2004).
Conference contributions — refereed
1) S. Mangia, G. Garreffa, M. Bianciardi, F. Giove, F. Di
Salle, R. Morrone, B. Maraviglia. Lactate concentration
during neuronal activation studied by 1H–MRS. Proceedings INF-
Meeting, National Conference on the Physics of the Matter, Roma
(Italy), 18–22 June 2001, pag. 159.
2) S. Mangia, G. Garreffa, F. Di Salle, R. Morrone, F.
Giove, B. Maraviglia. Evaluation of cerebral perfusion by ASL
(Arterial Spin Labeling) techniques in healthy and pathological
condition. Proceedings INFMeeting, National Conference on the
Physics of the Matter, Roma (Italy), 18–22 June 2001, pag. 104.
3) S. Mangia, F. Giove, M. Bianciardi, G. Garreffa, F. Di
Salle, B. Maraviglia. Lactate dynamics during activation of
the human visual cortex. 9th Annual Meeting of the Organization
for Human Brain Mapping, New York (USA), 18–22 June 2003.
Available on CD-ROM in NeuroImage, AbsTrak ID: 18747
4) F. Giove, S. Mangia, G. Garreffa, G. Giulietti, C. Co-
lonnese, B. Maraviglia. Functional NMR imaging of the spinal
cord at 1.5 T. Proceedings INFMeeting, National Conference on
the Physics of the Matter, Genova (Italy), 23–25 June 2003, pag.
85–86.
5) M. A. Macr`ı, G. Garreffa, F. Giove, A. Ambrosini, M.
Guardati, F. Pierelli, J. Schoenen, C. Colonnese, B. Ma-
raviglia. An in vivo 1H–MRS investigation of cerebellum: an
alternative approach for the assessment of some metabolic dys-
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functions. Proceedings INFMeeting, National Conference on the
Physics of the Matter, Genova (Italy), 23–25 June 2003 , pag. 108.
6) F. Giove, S. Mangia, G. Garreffa, G. Giulietti, C. Co-
lonnese, B. Maraviglia. Functional MR imaging of the human
spinal cord at 1.5 T. 10th Annual Meeting of the Organization for
Human Brain Mapping, Budapest (Hungary), 14–17 June 2004.
Available on CD-ROM in NeuroImage, Vol. 22.
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